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Malaria is the world's most important tropical parasitic disease and protozoa 
Plasmodium falciparum causes the most serious form of human malaria. The 
merozoite surface proteins MSP 142 and MSPI19 of P. falciparum are two leading 
malaria vaccine candidates. We are interested in using plants as expression system 
for their production. Our previous work on their expression in plants has not been 
successful, even at the transcriptional level, probably due to the numerous 
transcript-destabilizing sequences in the protozoa's genes. This has led to the 
modification of the cDNAs to avoid those signals and optimize their codon usages. 
Further, two sets of expression vectors were developed to optimize the expression, 
stability, and accumulation of the modified MSP 142 and MSPI19 proteins in 
transgenic plants. They were constructed by fusing the modified cDNAs either with 
the sequence of a highly expressed and stable plant protein (Lysine-rich protein from 
Winged bean) or the vacuolar-sorting tetrapeptide signal (AFVY) of phaseolin. 
These two sets of expression constructs, driven by the seed-specific phaseolin 
promoter, were studied using Arabidopsis as a model plant system. Expression of 
these genes has been detected for both constructs by northern & western blotting, 
amounting to 0.2% as total soluble seed protein. Remarkably, the recombinant 
X 
MSP 142 with the vacuolar-sorting signal maintains its natural antigenicity, being 
recognized by sera from patients infected with P. vivax. Confocal 
immunofluorescence studies also indicated that the MSPI42-AFVY was targeted to 
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Chapter 1 General Introduction 
Malaria is one of the most important diseases in the world. Currently, about 
40% of the world population, inhabiting in more than 90 countries, are at risk to 
malaria. There are an estimated 300-500 million new cases and 1-3 million deaths 
annually. With the spread of drug-resistant parasites and insecticide-resistant 
mosquitoes, an effective vaccine against malaria is an urgent need. In the 
development of a malaria vaccine, besides identifying the right antigen target, the 
cost of vaccine itself represents another major challenge. Since 90% of the disease 
burden occurs in the under-developed sub-Sahara African countries, funds for 
immunization program would be very limited. Thus, only those vaccines, where their 
costs are sufficiently low, would allow widespread vaccination of the people at risk 
among these countries. 
Using transgenic plants as the vaccine production system represents a very 
promising candidate in addressing this problem. It offers to produce both safe and 
functional antigens at a low cost. Importantly, another advantage is its ability to be 
used as edible vaccine. This not only could reduce the cost in further purification, but 
also may save costs in storage and transport and allow ease of administration. 
The protozoan Plasmodium falciparum is the cause of most cases of human 
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malaria and P. falciparum merozoite surface protein 1 (MSPl) is the leading malaria 
vaccine candidate. Its C-terminal fragments, MSPI42 and MSPl 19, have been found 
to confer protection against parasite challenge in Aotus monkeys immunized with the 
fragments. 
In an ultimate goal to produce low cost malaria vaccine in plant, we have 
previously attempted to express the MSPl42 cDNA in transgenic plants but have 
failed at transcriptional level, probably due to the numerous mRNA destabilizing and 
processing signals present in the parasite cDNA. Study by another group has been 
able to detect the mRNA of MSPl 19, however, the recombinant MSPl 19 was 
accumulated poorly in plant, only accounting for 0.0035% of the total soluble 
protein. 
In the present study, by designing a plant-optimized MSPl42 cDNA and fusing it 
with the stable lysine-rich protein (LRP) or phaseolin vacuolar-sorting signal 
(AFVY)，we hope to enhance the transcriptability and protein accumulation of the 
MSPl42 and MSPl 19 in transgenic plants and yield a better expression of these 
antigens for practical use. 
2 
Chapter 2 Literature Review 
2.1 Malaria 
2.1.1 Global situation 
Malaria is the world's most important tropical parasitic disease (WHO, 1998). It 
is a public health problem in 90 countries throughout the tropical and sub-tropical 
regions of the world, with almost half of them located in Africa south of the Sahara. 
It affects the 2.4 billion people, or 40% of the world population, inhabiting in this 
regions. Malaria exacts a heavy toll each year with 300-500 million cases and 1-3 
million deaths. Children and pregnant women in Africa are the most vulnerable. 
Every 40 seconds, an African child dies of malaria. It also poses a risk to travelers 
and immigrants to the areas, with importing cases increasing in non-endemic areas. 
While over 90% of the disease burden and nearly all death occur in sub-Sahara 
Africa, most of the remaining burden is distributed between the Indian sub-continent, 
Southeast Asia and Oceania, and the Americas. 
The economic burden of malaria also is extremely high (Sachs & Malaney, 
2002). It accounts for a drop of 1.3% in the annual economic growth rate in the 
endemic countries and that the long-term cumulative effect (from 1965-1990) in 
these countries on their gross national product (GNP) per capita is estimated as a 
50% reduction. 
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2.1.2 Malaria parasite and its life cycle 
Malaria is a vector-bome disease caused by the protozoan parasites of the 
Genus Plasmodium. Four species of Plasmodia infect human. These are Plasmodium 
falciparum, P. vivax, P. malaria and P. ovale, while the first species is the most 
virulent form, accounting in large part for the extremely high mortality in Africa. All 
four species are transmitted by anopheline mosquitos. 
The life cycle of the malaria parasite is complex (Miller et al, 1986; Miller et 
al., 2002). It comprises the exoerythrocytic stage, the asexual erythrocytic stage and 
the sexual transmission stage. The exoerythrocytic stage begins with the bite of an 
infected female anopheline mosquito, which introduces the sporozoites to the 
subcutaneous tissue of the human body. From there, the sporozoites travel to the 
blood stream and circulate for a short time, then invade liver cells, where they 
develop into exoerythrocytic schizonts. A mature exoerythrocytic schizont contains 
10,000-30,000 merozoites, which are released to the blood stream when the hepatic 
cells rupture. The invasion of these merozoites to the erythrocyte marks the start of 
the asexual erythrocytic stage. The merozoite develops within the erythrocyte 
through ring, trophozoite and schizont (erythrocytic schizont). The erythrocyte 
eventually ruptures and releases the merozoites, which invade additional erythrocytes. 
As this cycle repeats, the clinical symptoms of malaria emerge. At this stage, malaria 
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can kill by infecting and destroying red blood cells (anaemia) and by clogging the 
capillaries that carry blood to the brain (cerebral malaria) or other vital organs. In the 
sexual transmission stage, some merozoites, instead of forming schizonts in the 
erythrocytes, differentiate into sexual forms, which are macrogametocytes (female) 
and microgametocytes (male). When a female anopheline mosquito takes up the 
gametocytes, they fertilize and form a zygote in the mid-gut. The zygote then mature 
into a motile ookinete, which travel and mature into an oocyst beneath the basement 
membrane of the mid-gut. A single oocyst forms more than 10,000 sporozoites. The 
motile spozoites migrate into the salivary glands and, when the infected mosquito 
bites another human host, the Plasmodium life-cycle begins again. 
2.1.3 Need for a malarial vaccine 
Malaria has been classified as an "emerging infection" by many national and 
international health authorities (Lederberg et al., 1992), due to the increased global 
incidence of the disease. The situation becomes more worrying with the spread of 
drug-resistance strains of parasites (Wellems and Plowe, 2001) and 
insecticide-resistant strains of mosquito vectors (Suarez et al, 1990), making the 
current use of anti-malarial drugs and insecticide much less effective in combating 
malaria. In this context, the development of effective malarial vaccines, which offer 
one of the most cost-effective approaches, would be in great urgency to reduce the 
5 
malarial infection and disease (Miller and Hoffman, 1998). 
In the past two decades, there has been a great deal of research on malarial 
vaccine development, though there is currently no effective vaccine available for 
widespread use. Vaccine research has been focusing on the identification of 
conserved, immunogenic regions of surface antigens of different life cycle stages 
(Miller and Hoffman, 1998; Richie and Saul, 2002). Three types of vaccine are under 
development: 
(i) Anti-sporozoite vaccines, designed to prevent infection 
(ii) Transmission blocking vaccines, designed to arrest the development of the 
parasite in mosquito, and 
(iii) Anti-asexual blood stage vaccines, designed to lessen disease by reducing 
blood stage asexual parasite (merozoite) burden 
As the asexual blood stage is the only stage of the parasite life cycle that causes 
the clinical symptoms and resulting death, the development of the anti-asexual blood 
stage vaccines would be the most urgent in reducing malaria-associated severe 
morbidity and mortality in the endemic areas. Among these vaccine targets, P. 
falciparum merozoite surface protein 1 (MSPl) is the most studied and is the leading 
anti-asexual blood stage vaccine candidate. 
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2.2 Merozoite surface protein 1 and its fragments - the advanced 
malaria vaccine candidate 
2.2.1 Basic research on MSPl 
Merozoite surface protein 1 (MSPl), which is expressed in all species of 
Plasmodium, is a family of structurally similar large merozoite surface proteins, with 
a relative mobility in SDS-PAGE of 185-215 kDa (depending on the species). It is 
synthesized during schizogony and remains on the surface of free merozoites (Diggs 
et al, 1993). 
MSPl, as shown most thoroughly in studies of P. falciparum and P. knowlesi, 
undergoes extensive specific proteolytic processing. At the time of merozoite release, 
the high molecular weight precursor is proteolytically cleaved into a series of smaller 
molecules (83 kDa, 30 kDa and 38 kDa) which remain loosely attached to the 
merozoite surface by non-covalent interactions with the 42 kDa carboxyl terminal 
fragment, MSPI42 (Holder et a l , 1987; McBride and Heidrich, 1987). MSPI42 binds 
to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor (Ceroid et 
al., 1996). Upon invasion of erythrocyte, MSPI42 has to be cleaved into MSPl 19, 
which remains on the surface (Holder et al., 1992), and MSPl33，which is shed from 
the surface as part of a complex with the fragments from the primary processing step 
(Blackman et ai, 1991). MSPl 19, which includes two cysteine-rich epidermal growth 
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factor (EGF)-like domains (Blackman et al, 1991) and the GPI anchor, enters with 
the invading merozoite into the erythrocyte. The actual function of MSP 1 remains to 
be found, but studies have indicated its possible role in the attachment of the 
merozoite to the erythrocyte, through the interaction with erythrocyte spectrin 
(Herrera et aL, 1993). 
2.2.2 Vaccine research on MSPl 
MSPI42 is the prime vaccine candidate based on a large number of studies 
indicating its involvement in protective immune responses. Protection against 
malaria was studied by challenging the animal model New World primate Aotus 
lemurinus griseimembra, which has been shown to be a suitable model for evaluating 
human malaria vaccine (Siddiqui, 1977)，with intravenous inoculums of parasite 
infected erythrocytes. Para sitemias (a condition in which parasites are present in the 
blood) of the animals were monitored by blood smears and protected animals would 
become aprasitemic, free of detectable parasites, or having a very low parasitemia. 
Immunization of Aotus monkeys with a purified MSPl from P. falciparum 
induced complete protection against a lethal challenge with the parasites (Siddiqui et 
al.，1987). Also, serum from these monkeys inhibited the in vitro growth of the 
parasite (Hui and Siddiqui, 1987), suggesting protection is antibody dependent. 
Further research indicates that the C-terminal region of MSPl, which contains the 
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two EGF-like domains, could be sufficient in inducing protective immunity. 
Protection against P. falciparum challenge has been achieved in monkeys immunized 
with recombinant MSPI42 (Chang et al” 1996) or recombinant MSPl 19 (Kumar et al.， 
1995). Though MSPl 19 is considered to be the minimal fragment for protection (Hui 
et al., 1994)，but MSPl 19 lacks sufficient T-cell epitopes and has poor 
immunogenicity (Egan et al., 1997), MSPI42 thus appears to be a better candidate. 
To date, a number of expression systems have been employed to produce the 
C-terminal fragments of MSPl as recombinant vaccine. These include bacteria 
(Holder et al., 1988; Wu et al.’ 2000), yeast (Chang et al, 1992; Kaslow et al, 1994), 
baculovirus system (Murphy et al, 1990; Chang et al, 1992), and more recently in 
baculovirus-silkworm system (Pang et al, 2002), in the milk of transgenic mice 
(Stowers et al., 2002) and in transgenic tobacco (Ghosh et al, 2002). Unlike the 
baculoviral and animal systems, MSPl-based vaccine produced in bacteria, yeast and 
its derived synthetic peptide (Cheung et al., 1986) generally could not form the 
EGF-like domains and are less effective for inducing protection. These studies have 
indicated that the folding of the recombinant MSPl42 C-terminal fragments into its 
native, conformational epitopes, probably the formation of the two correctly folded 
EGF-like domain, is critical for the generation of parasite growth-inhibitory 
antibodies and to confer protection (Locher and Tarn, 1993; Stowers et al” 2001). 
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In addition, the yield of expressing MSPI42 in the cell culture of baculovirus 
system, the baculovirus-silkworm system (Pang et al., 2002) and in the milk of 
transgenic mice (Stowers et al., 2002) were 2.4 to 3.5 |ag/ml of medium, 379 |ag/ml 
of hemolymph and 840 |ag/ml of purified antigen, respectively. 
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2.3 Transgenic plants as recombinant protein production systems 
2.3.1 Characteristics 
With the advances in recombinant DNA technology, plant molecular biology 
and plant transformation, transgenic plants have emerged as an attractive expression 
system for large-scale production of industrial enzymes and pharmaceutical proteins 
(Goddijn and Pen, 1995; Daniell et al, 2001). For an ideal expression system, one 
should be able to produce the most safe, biologically active materials at the lowest 
cost. In view of this, transgenic plants hold many advantages against expression 
systems like human or animal fluids or tissues, bacteria, yeast, transfected animal cell 
lines, or transgenic animals (Table 2.1，from Fischer et al., 1999). These include low 
costs of cultivation, low capital and operating costs, ease in scaling up, eukaryote 
post-translational modification system, low risk of human and animal pathogens, and 
a relatively high protein yield. When driving the expression of proteins under 
tissue-specific promoters, such as seeds, this offers another advantage in ease of 
storage and transport. 
However, there are currently a few impediments in using plants as the 
expression systems. These include low level of protein expression, the present of 
complex-type glycan and the often-observed post-transcriptional gene silencing. It is 
clear that more research would be needed in order to address these problems. 
11 
Table 2- 1: Comparison of features of recombinant protein production in plants, yeast 
and conventional systems 
Transgenic 丨 丨 Mammalian- | Transgenic 
Plant viruses Yeast Bacteria 
plants cell cultures animals 
Risk* Unknown Unknown Unknown Yes Yes Yes 
Production cost Low Low Medium Medium High High 
Time effort High Low Medium Low High High 
Low (unlimited Low (unlimited 
Scale-up cost High^ High^ High^ High 
biomass) biomass) 
Production Worldwide Worldwide Limited Limited Limited Limited 
Product yields High Very high High Medium Medium-high High 
Folding accuracy High? Medium Medium Low High High 
Product 
High? Medium Medium Low Medium Low 
homogeneity 
Multimeric protein 
Yes No No No No Yes 
assembly (sIgA) 
Gene size Not limited Limited Unknown Unknown Limited Limited 
Glycosylation "Correct"? "Correct"? Wrong Missing "Correct" "Correct" 
Production vehicle Yes Yes Yes Yes Yes Yes 
Delivery vehicle Possible Possible No No No Yes 
Cheap/room 
Storage Cheap/-20°C Cheap/-20°C Cheap/-20X Expensive/Nz ？ / N 2 
temperature 
Distribution Easy Easy Feasible Feasible Difficult Difficult 
Ethical concerns Medium Medium Medium Medium Medium High 
* Residual viral sequences, oncogenes and endotoxins. 
卞 In terms of large fermenters etc. 
(Adopted from Fischer et al., 1999) 
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2.3.2 Plant-based vaccine 
Sub-unit vaccines are specific macromolecules, mainly proteins, which induce 
a protective immune response against a pathogen. As they avoid the use of live 
pathogens, sub-unit vaccines are the preferred approach for vaccine developers 
nowadays. However, the cost of current sub-unit vaccines, which include production, 
packaging, storage and delivery, is high and this often precludes their availability to 
the developing countries, where the number of at-risk individuals is among the 
highest. 
Using plants as the vaccine production system could eliminate most of these 
problems, as stated above (2.3.1). Transgenic plants could potentially produce high 
level of functional and safe antigen at a low cost that could be harvested in 
agricultural scale for use in parenteral or oral vaccines. When taken as an oral 
vaccine, this could further reduce the cost in the purification of antigen and its 
delivery. 
Since the research began in the early 1990s, plant-derived edible vaccine has 
proved to be a feasible approach in vaccination (Walmsley and Amtzen, 2003). This 
has attracted an increasing number of researchers and many different plants 
expressing different antigens have been reported. Earlier studies include the 
expression of the hepatitis B surface antigen in tobacco and lettuce (Mason et al., 
13 
1992; Ehsani et al.’ 1997), a cholera antigen, LT-B, in tobacco and potatoes (Hein et 
al, 1995; Arakawa et al., 1997) and a human cytomegalovirus antigen in tobacco 
(Tackaberry et al” 1999). Further, oral immunogenicity of the plant-based edible 
vaccines in animals has been demonstrated in potato-derived LT-B (Haq et al., 1995), 
Norwalk virus antigen (Mason et al., 1996) and hepatitis B surface antigen (Richter 
et al.’ 2000). To date, three edible plant vaccines, potato-derived LT-B (Tacket et al., 
1998)，potato-derived Norwalk virus antigen (Tacket et al, 2000) and lettue-derived 
hepatitis B surface antigen (Kapusta et al., 1999)，have been tested in human clinical 
trails and all shown to be capable of inducing an immune response and no adverse 
effects have been recorded. 
These results demonstrated that plant-based vaccines are both safe and 
functional and show great promise to allow low cost vaccination program in the 
future. Further research would need to improve plant expression technology, develop 
appropriate plant species for the delivery and gain more knowledge on mucosal 
immunology. 
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2.4 Expression of MSPl C-terminal fragments in transgenic plants 
2.4.1 Previous studies 
Until now, there are two studies reported the expression of MSPl C-terminal 
fragments in transgenic plants (Ng, 2001; Ghosh et al., 2002). However, both results 
were not satisfactory. 
2.4.1.1 Poor transcription 
Our group has previously attempted to express MSPl42 in transgenic tobacco 
and Arabidopsis (Ng, 2001). The cDNA, encoding MSPl42 of the Plasmodium 
falciparum Uganda Palo Alto (FUP) strain, was cloned and placed downstream of the 
seed-specific Phaseolin promoter. Transgenic tobacco and Arabidopsis, carrying the 
transgene, was generated. However, only truncated transcripts of MSPl42 were 
detected in some transgenic Arabidopsis lines by RT-PCR and no signal was 
observed in all lines by northern blot analysis. For the transgenic tobacco, no 
transcription was detected in both RT-PCR and northern blot. Further, western blot 
and a particle bombardment experiment using C-terminal fusion of GUS to MSPI42 
cDNA all showed negative results. These results suggested that the expression of 
MSPI42 in transgenic plants was impeded at transcriptional level. 
Through analysis of the transgene, the cDNA sequence of MSPl42 was 
suspected to be the cause for its poor transcription. The AT content of MSPI42 cDNA 
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is exceptionally high, about 70% of its coding sequence as AT. More importantly, it 
includes nine ATTTA pentamers, which are mRNA destabilizing sequences 
(Ohem-Takagi et al.’ 1993), and, strikingly, 24 AATAAA/AATAAA-like motifs 
(Joshi, 1987)，which are putative polyadenlyation signals in plants (Figure 2- 3). The 
presence of these numerous mRNA destabilizing and processing motifs probably 
accounts for the poor transcription of the transgene in plants. 
2.4.1.2 Poor protein accumulation 
In another study by a group from India (Ghosh et al., 2002), the gene, 
encoding the Plasmodium falciparum MSPl 19 from an Indian isolate, was cloned 
into pBI121 and placed under the constitutive 35S promoter of cauliflower mosaic 
virus. Transgenic tobacco was then generated. Transcription of the MSPl 19 cDNA 
was successfully detected by northern blot analysis. The protein, MSPl 19, was also 
found to express by enzyme linked immunosorbent assay (ELISA) and western 
analysis. However, the protein level was quite low. Maximum level of expression 
was only 0.0035% of the total soluble protein (TSP). Therefore, it required 5 mg of 
concentrated total soluble protein in order to detect the recombinant protein in the 
western blot. Due to the low level of protein expression, further analysis of the 
plant-derived MSPl 19 was not possible. 
Since the MSP 19 sequence of the FUP strain and the Indian strain differ by 
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only four nucleotides, the major reason for the successful transcription of MSPl 19 in 
the later study but not in MSPl42 might be due to their different in size. The cDNA 
of MSPl 19 accounts for the 3' terminal 303 bp of the 1122 bp of MSPl42 cDNA. 
Consequently, the destabilizing and the processing signals are reduced to 1 and 4 
respectively (Figure 2- 3). This difference might allow for the transcription of the 
smaller MSPl 19cDNA. 
The authors explained the low level of MSPl 19 in the transgenic tobacco in 
terms of the large number of cysteine residues in the MSPl 19 protein. Some studies 
have reported that the expression of the normally secreted proteins, particularly those 
with disulphide bridges, in the cytoplasm of plant cell was very low (Bosch et al, 
1994; Florack et al” 1994). This might be due to the degradation or destabilization of 
the protein in the highly reducing environment and this might result in the low level 
of MSPl 19 in plant. 
Apart from the authors' explanation, the codon usage of the MSPl 19 may also 
be unfavorable for translation in plants. In plant, most genes preferentially use G/C at 
the degenerate third base of the codons (Murray et al, 1989). Since most of the 
codons in MSPl 19 use A/T at the third base, these might result in poor translation of 
the protein. Moreover, although having less destabilizing and processing signals, the 
MSPl 19 transcript might still be destabilized by these signals, preventing the 
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transcripts to be accumulated to a high level for translation. Further, the 35S 
promoter used in the study is not a strong promoter, as its expression level in general 
is below 1% of TSR All of these might explain the low expression level of MSP 119 in 
the transgenic tobacco. 
2.4.2 Plant-optimized MSPI42 cDNA 
From the previous studies, obviously, the first step to improve the expression of 
MSP 142 lies in optimizing its gene for the plant transcriptional and translational 
machinery. 
Our group (Wang and Sun) has designed a plant-optimized MSP 142 cDNA for 
plant expression. The modification criteria were based on reducing the AT content, 
removing the mRNA destabilizing sequences and polyadenylation signals, avoiding 
A/T at the third degenerate bases and optimizing codon usage for plant. After the 
reconstitution, 294 nucleotides were changed, while the coding amino acids 
remained the same. The AT content was decreased from 72.5% to 50.2% and all of 
the destabilizing and processing signals were avoided. The A/T at the third 
degenerate bases was decreased to 18.7% and the codons were more plant-based. 


























Figure 2- 3. Nucleotide sequence of the merozoite surface protein 1, 42- and 
19-kDa fragment, (MSPI42 & MSPI19) cDNA of the Plasmodium 
falciparum Uganda Palo Alto (FUP) strain 
The total length of the MSP 142 cDNA is 1122 bp, wherease the length 
of the MSPI19CDNA is 303 bp (underlined). The mRNA destabilizing 
sequence (bracketed) and the putative polyadenylation signal (shaded) 
are also shown. 
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2.5 Phaseolin: its promoter and vacuolar-sorting signal 
Phaseolin is the major storage protein of common bean {Phaseolus vulgaris) 
seed. It comprises of three polypeptide variants: a , (3, and y, of 51-53, 47-48, and 
43-46 kDa, respectively (McLeester et al., 1973) and represents about 50% of the 
total protein in mature seeds (Ma and Bliss, 1978). These proteins are accumulated 
rapidly in the seed cotyledon, beginning around 12 days after anthesis and continuing 
over the following week (Sun et al, 1978). 
The complete nucleotide sequence of p-phaseolin was determined in the 
early 80s (Sun et al, 1981; Slightom et al” 1983) and later its promoter was 
characterized (Sengupta-Gopalan et al., 1985; Bustos et al, 1989). Remarkably, the 
spatial (embryo-specific) and temporal (developing) regulation of phaseolin 
promoter was maintained in transgenic tobacco, where phaseolin itself or GUS were 
expressed. Since the phaseolin promoter yields strong and seed-specific expression, 
it has been utilized in expressing foreign proteins in plants. These include expression 
of the Brazil nut 2S albumin in transgenic tobacco and canola seeds (Altenbach et al., 
1989; Altenbach et al, 1992) and maize zein protein in transgenic tobacco seeds 
(Hoffman et al, 1987). 
In addition, a number of studies have been carried out to elucidate the 
intracellular trafficking of phaseolin (Bollini et al., 1982; Sturm et al, 1987; 
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Lawrence et al, 1994). Phaseolin is a homotrimeric soluble glycoprotien that is 
accumulated in the protein storage vacuoles. It is cotranslationally introduced into 
the lumen of endoplasmic reticulum where it assembles into trimers. It then passes 
through the Golgi complex to the storage vacuoles. Recent studies have pointed to 
the last four C-terminal amino acids, AFVY, of phaseolin as the necessary 
determinant for its vacuolar sorting (Frigerio et al, 1998; Frigerio et al., 2001). A 
mutated phaseolin, lacking the AFVY, was able to form trimers in the ER but was 
entirely secreted outside of the cells in transgenic tobacco leaves. Moreover, when 
AFVY was fused to the secreted version of green fluorescent protein (GFP)，the 
secretion of GFP was inhibited and GFP-AFVY was found to accumulate in vacuoles. 
These studies demonstrated that the phaseolin tetrapeptide AFVY contains sufficient 
signal for vacuolar targeting. 
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2.6 Sorting of soluble protein to vacuoles in plants 
Plant cells contain at least two structurally and functionally distinct vacuoles: 
the lytic vacuole (LV) and the protein storage vacuole (PSV) (Paris et al, 1996; 
Neuhaus and Rogers, 1998). While LV/lysosome is common across eukaryotes, PSV 
appears to be unique to plant cells and has been found to contain three 
sub-compartments (Jiang et al., 2000). Further, tonoplast intrinsic proteins (TIPs), 
which are integral membrane proteins in the tonoplast, serve as markers for different 
vacuolar functions. The tonoplasts of LV and PSV are marked by y-TIP and a-TIP, 
respectively (Jauh et al” 1999). 
Three vesicular pathways for the transport of soluble proteins to different 
vacuoles in plant cells have been described so far. The first route is via the 
Golgi-derived clathrin-coated vesicles (CCVs) to the prevacuolar compartment (PV) 
of the LVs (Jiang and Rogers, 1998). The second route is marked by Golgi-derived 
dense vesicles (DVs) that carry storage proteins such as provicilin to a prevacuolar 
compartment (PVC) and then to PSVs (Robinson et al., 1998). The third route is a 
direct ER to PSV pathway, represented by the delivery of storage proteins via 
ER-derived precursor accumulating (PAC) vesicles (Hara-Nishimura et al., 1998) or 
dark intrinsic protein (DIP) organelles (Jiang et al., 2000). 
Vacuolar sorting of proteins in plant is dependent on the vacuolar sorting 
2 2 
signals, present as protein motifs, on the proteins. The vacuolar signals are diverse 
and could be classified to three classes: the N-terminal propeptide signals, such as 
the NPIR-motifs on the sweet potato sporamin (Neuhaus and Rogers, 1998), the 
C-terminal propeptide signals (e.g. in barley lectin; Bednarek et al., 1990), and the 
internal sorting signals (von Schaewen and Chrispeels, 1993). The phaseolin 
vacuolar sorting signal, AFVY, being a C-terminal propetide signal, represents the 
shortest known signal to mediate the sorting process (Frigerio et al., 1998; Frigerio et 
< 2 0 0 1 ) . 
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2.7 Winged bean lysine-rich protein and translational fusion strategy 
The lysine-rich protein (LRP) from winged bean (Psophocarpus tetragonolobus) 
is a seed protein with high lysine content (~11 mol%). The biological function of 
LRP is not well understood, but a recent study showed it has high homology to the 
class 10 pathogenesis-related proteins and has RNase activity (Wong, 2002). 
Since LRP contains this high amount of the essential amino acid, research has 
been carried out to cloned and express LRP in transgenic Arabidopsis (Cheung, 1999) 
and rice (Liu, 2002) with an aim to improve the nutritional value of cereal crops. In 
Ambisopsis, LRP was found to express at a very high level (8-10% as total protein) 
when driven by the seed-specific phaseolin promoter. Even higher expression level 
(-12%) was observed in transgenic rice, driven by the glutelin (Gtl) promoter. Both 
studies demonstrated that LRP could be stably expressed and accumulated in 
transgenic plants. 
The first report employing the translational fusion strategy in enhancing protein 
expression in plant utilized ubiquitin as the fusion partner (Hondred et al.’ 1999). 
Ubiquitin (UBQ) is a highly stable and abundant protein in eukaryotes and functions 
in the selective protein degradation. In the report, UBQ was used as a N-terminal 
fusion to glucuronidase or luciferase. In transgenic tobacco, the UBQ-glucuronidase 
(UBQ-GUS) and UBQ-luciferase (UBQ-LUC) fusion proteins were found to express 
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at a higher level than the non-fusion ones. The amount increases in the UBQ fusion 
lines, as estimated by enzymatic assays, were 4.1 and 2.2 times, respectively. The 
authors' explanation for the enhancements was that the UBQ moiety might facilitate 
folding and/or stability of the nascent polypeptide or shield the protein from 
contranslational degradation. Also, the enhanced translation might stabilize the 
mRNA by association with polysomes. 
With an aim to make use of the stability of LRP in transgenic plants, LRP fusion 
construct was constructed (Lo, Dept. of Biology, CUHK). The fusion construct 
allows the expression of LRP as a fusion partner to a foreign protein, providing 
possible stabilizing effects for the foreign protein accumulation. 
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2.8 Hypotheses and aims of study 
On the basis of the previous studies, it becomes clear that, to express the 
parasite MSPI42 or MSPl 19 in plants, the problems encountered in its transcription 
and protein expression should be resolved. In this study, we propose to utilize the 
plant-optimized MSPl42 cDNA and fuse it with the stable lysine-rich protein (LRP) 
or the phaseolin vacuolar-sorting signal (AFVY) to address these problems. The 
hypotheses are: 
(1) By optimizing the MSPl42/19 cDNA sequence, the transcript stability and 
translational efficeincy of the transgenes in plant would be enhanced. 
(2) By fusing MSPl42/19 with lysine-rich protein or the phaseolin 
vacuolar-sorting signal, the stability and accumulation of the expressed 
proteins in plant would also be enhanced. 
To test the hypotheses, expression vectors harboring the lysine-rich fusion 
constructs or phaseolin targeting constructs, with the plant-optimized MSPl42 cDNA 
driven by the seed-specific phaseolin promoter, would be constructed and 
transformed into Arabidopsis as a model plant system. Expression of the transgenic 
plants would then be analyzed by molecular techniques. 
The goal of this study is to develop expression vectors that would optimize the 
expression, stability and accumulation of the modified MSPI42&19 in transgenic 
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plants and allow subsequent immunological and biochemical analysis. 
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Chapter 3: Materials and Methods 
3.1 Introduction 
The expression of the modified MSPl 42 or MSPl 19 cDNA in lysine-rich fusion 
constructs and the phaseolin-targeting constructs were tested in transgenic 
Arabidopsis, whereas the sub-cellular localization of MSPl42-AFVY was performed 
in transgenic tobacco. 
3.2 Chemicals 
All the chemicals used were of reagent grade or molecular grade (unless 
otherwise specified) and were purchased from Sigma Chemical Co. or Bio-Rad Co. 
(unless otherwise specified). 
3.3 Bacterial strains 
E. coli DH5a was employed in the construction of chimeric gene constructs. 
Agrobacterium tumefaciens GV3101/pMP90 (Koncz and Schell, 1986) and 
LBA4404/pAL4404 (Hoekema et al., 1983) were used for Arabidopsis and tobacco 
transformation, respectively. 
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3.4 Chimeric gene construction 
The Plasmodium falciparum Uganda Palo Alto (FUP) strain, merozoite surface 
protein 1，42-kDa fragment (MSPI42) cDNA, (from Alanss to Sernos) in plasmid 
pUC18::flgp42-His was obtained from Prof. Sandra. P. Chang of the Department of 
Tropical Medicine and Medical Microbiology, University of Hawaii (Figure 3- 1). 
The C-terminal region of the MSPI42 (from Glyi609 to Serivos) represents the smaller 
19-kDa fragment (MSPl 19). The plant-optimized MSPl42 cDNA (including region 
encoding MSPl 19) was designed as described in 2.4.2 (Figure 3- 2), which encodes 
the same amino acid sequence as MSPI42 and MSPl 19 (Figure 3- 3), and was 
synthesized by Integrated DNA Technologies, Inc. 
The cDNAs was cloned in two sets of expression vectors: the lysine-rich fusion 
constructs and the phaseolin-targeting constructs, both driven by the seed-specific 
phaseolin promoter. The resulting chimeric genes were then cloned into the 
Agrobacterium binary vector pBI121 for plant transformation. 
For simplicity, P42 and P19 would represent the unmodified MSPl42 and 
MSPl 19 cDNAs, whereas MP42 and MP 19 would represent the plant-optimized 

























Figure 3- 1. Nucleotide sequence of cDNA encoding the merozoite surface 
protein 1，42- and 19-kDa fragment (MSPI42 & MSPI19)，of the 
Plasmodium falciparum Uganda Palo Alto (FUP) strain 
The total length of the MSP 142 cDNA is 1122 bp, including the stop 


























Figure 3- 2. Nucleotide sequence of plant-optimized cDNA encoding the 
merozoite surface protein 1, 42- and 19-kDa fragment (MSPl42 & 
MSPl 19), of the Plasmodium falciparum Uganda Palo Alto (FUP) 
strain 
The total length of the mMSPUi cDNA is 1122 bp, including the stop 







FKNHNDFEAIKKLINDDTKKDMLGKLLSTGLVQNFPNTI工 S KLIEGKFQDMLNISQH 
QCVKKQCPENSGCFRHLDEREECKCLLNYKQEGDKCVENPNPTCNENNGGCDADAKC 
TEEDSGSNGKKITCECTKPDSYPLFDGIFCS 
Figure 3- 3. Amino acid sequence of MSPI42 and MSPI19 
The 42-kDa fragment consists of 373 amino acids with a calculated 
MW equals to 42.8 kDa, whereas the 19-kDa fragment consists of 100 
amino acids (underlined) with a calculated MW equals to 11.2 kDa. 
1) pTZ/Phas/LRP 12A/MP42 
PhaSpro LRPl EK MP42 EK LRP2 Phaster 
2) pTZ/Phas/LRP 12B/MP42 
PhaSpro LRPl I EK | MP42 EK LRP2 His Phaser 
3) pTZ/Phas/LRP12A/P42 
PhaSpro I LRPl I EK | P42 EK LRP2 Phaster 
4) pTZ/Phas/LRP12B/P42 
PhaSpro LRPl I EK | P42 | EK LRP2 His PhaSter 
Figure 3- 4. Structure of the lysine-rich fusion constructs 
Four chimeric gene constructs were designed with either P42 or M42 
inserted in between the LRP cDNA with or without His-tag. (PhaSpro： 
phaseolin promoter; LRPl: 1-135 bp of the lysine rich protein cDNA; 
EK: enterokinase site; LRP2: 136-480 bp of the lysine rich protein 
cDNA; His: His-tag and Phaster： phaseolin terminator) 
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3.4.1 Construction of the lysine-rich protein fusion constructs 
Four chimeric gene constructs including P42 and MP42, inserted in between the 
lysine-rich protein (LRP, at the 46"^  amino acid), with or without His-tag, and driven 
by the phaseolin promoter were prepared, as shown in Figure 3- 4. 
In their construction, the target genes (P42 or MP42) were first PGR amplified 
with specific primers that introduce a 5' Ncol site and a 3’ Ncol site plus an 
enterokinase (EK) sequence. For amplifying P42, primer set, LAN42 & RNEK42, 
was employed, using pTZ/Phas/EK/His/flgp42 (Ng, 2001) as template. For 
amplifying MP42, primer set, LANm42 & RNEKm42，was used, with pUC19/MP42 
as template. The primers sequences are shown in Figure 3- 5. A 50fil PGR reaction 
mixture containing 40ng DNA template, IX Pfu buffer (Strategene), 0.2mM dNTP, 
0.5|iM 5' primer, 0.5|iM 3' primer and 2.5units Pfu DNA polymerase (Strategene, 
2.5u/nl) was prepared for each of the target gene. The PGR conditions were as 
follows: 94°C for 5 minutes, then 25 cycles of 94�C for 30 seconds, 58°C for 30 
seconds and I T C for 30 seconds, followed by 1 cycle of 72°C for 7 minutes. 
The PGR products were digested with Ncol (New England BioLab) and cloned 
into pBKII/LRP12A or pBKII/LRP12B vector ("A" represents the no-His construct, 
while "B" represents the construct with C-terminal His-tag, Figure 3- 4)，which were 
constructed by Lo, Dept. of Biology, CUHK. The gene sequence was confirmed by 
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DNA sequencing (3.4.3). Then the whole LRP and target gene was cut out using 
AccI (New England BioLab) and cloned into pTZ/Phas vector (Yu, 2001) containing 
the phaseolin promoter and terminator (Figure 3-6). 
(A) Primers for the amplification of M42: 
AccI Ncol 
LANm42: 5‘AGTCTACCATGGCTATCTCTGTG ( 2 3 mer ) 
AccI Ncol 
LANmlS: 5‘AGTCTACCATGGGAAAGTTCCAAGACATG ( 2 9 m e r ) 
Ncol EKsite 
RNEKin42: 5'CATGCCATGGCCTTATCGTCATCGTCGCTGCAGAAGATACCGTCGA 
( 4 6 m e r ) 
(B) Primers for the amplification of P42: 
AccI Ncol 
LAN42: 5‘AGTCTACCATGGCGATATCTGTCACAAT ( 2 8 m e r ) 
AccI Ncol 
LAN19: 5‘AGTCTACCATGGGAAAATTCCAAGATATGTTA ( 3 2 m e r ) 
Ncol EKsite 
RNEK42: 5‘CATGCCATGGCCTTATCGTCATCGTCACTGCAGAAAATACCATCGA 
( 4 6 m e r ) 
Figure 3- 5. Primers for the amplification of P42 and MP42 for LRP fusion 
constructs. 
Bold sequences represent the gene sequences of either P42 (B) or 





Target gene ^ ^ ^ ^ ^ 
pTZ/Phas/EK/His/flgp42^^-N^°M 
or pUC19/MP42 ^ ^ ^ 
J PGR 
• Ncol Ncol 
AccI AccI LRPl EK LRP2 / 
Ncol Ncol 
Target gene EK pBKII/LRP12A 
�l i g a t i o n 
LRPl EK Target gene EK LRP2 / c c I 
r 1 I K Vw pBKII/LRP12A/Target gene 
丄 AccI digestion 
AccI AccI 
LRPl EK Target gene EK LRP2 
AccI AccI 
Hindlll Hindlll \ PhaSpro Phaster / 
( pTZ/Phas ) 
ligation 35 
，�l igat ion 
Hindlll Hindlll 
\ PhaSpro LRPl EK Target gene EK LRP2 Phaster / r S pTZ/Phas/LRP12A/Target gene ^ ^ ^ 
Figure 3- 6. General scheme of the construction of LRP fusion constructs 
Target gene represents either P42 or MP42. For the cloning of 
pBKII/LRP12B, a His tag sequence was present in between the LRP2 
and Phaster. The abbreviations used are the same as Figure 3- 4. 
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3.4.2 Construction of the phaseolin vacuolar-sorting constructs 
Four chimeric gene constructs including P42, PI9, MP42 and MP 19, fused with 
the phaseolin signal peptide and its AFVY vacuolar-sorting signal were generated 
(Fig. 3- 7). 
In their construction, the target genes (P42, PI9, MP42 & MP 19) were first 
amplified by PGR with specific primers that introduced a 5' Ndel site and a 3’ AccI 
site plus an AFVY sequence. The primer set and the template for each amplification 
were: 
Primer set DNA template 
P42: LNsp42, RAFVY42 pTZ/Phas/LRJP12A/P42 
P19: LNsp 19，RAFVY42 pTZ/Phas/LRP 12A/P42 
MP42: LNspM42, RAFVYM42 pUC19/M42 
MP19: LNspM19, RAFVYM42 pUC19/M42 
The sequences of the primers are shown in Figure 3-8. 
The PGR was carried out as described in 3.4.1 and the product was cloned into 
the pGEM®-T vector. The gene sequence was confirmed by DNA sequencing (3.4.3). 
The target gene was then excised by Ndel and AccI and cloned into the pBK/Phas/sp 
vector containing the phaseolin promoter, the phaseolin signal peptide sequence and 
terminator (Figure 3- 9). 
37 
1) pBK/Phas/sp/MP42-AFVY 
PhaSpro sp MP42 AFVY PhaSter 
2) pBK/Phas/sp/MP 19-AFVY 
PhaSpro sp MP19 AFVY Phaster 
3) pBK/Phas/sp/P42-AFVY 
PhaSpro sp P42 AFVY PhaSter 
4) pBK/Phas/sp/P19-AFVY 
PhaSpro I sp I PI9 AFVY Phaster 
Figure 3- 7. Structure of constructs with the phaseolin vacuolar-sorting signal 
AFVY 
Four chimeric gene constructs were designed with either P42, PI9， 
MP42 or MP 19 fused with the phaseolin signal peptide and 
vacuolar-sorting signal. (PhaSpro： phaseolin promoter; sp: phaseolin 
signal peptide; AFVY: phaseolin vacuolar-sorting tetrapeptide and 
Phaster: phaseolin terminator) 
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(A) Primers for the amplification of M42 & M19: 
N d e l 
LNspM42 : 5 ‘ CCATATGCCACTTCACTCGCTATGTCTGTGACTATGG ( 3 7 m e r ) 
N d e l 
L N s p M 1 9 : 5 ‘ CCATATGCCACTTCACrCGGAAAGTTCCAAGACATGC ( 3 7 m e r ) 
A c c I 
RAFVYM42:5'AGTATACAAATGCGCTGCAGAAGATACCGTC ( 3 1 m e r ) 
(B) Primers for the amplification of P42 or P19: 
N d e l 
L N s p 4 2 : 5 ‘ CCATArGCCACTrCACTCGCGATATCTGTCACAATGG ( 3 7 m e r ) 
N d e l 
L N s p l 9 : 5 , CCATATGCCACTTCACTCGGAAAATTCCAAGATATGTTA ( 3 9 m e r ) 
A c c I 
RAFVY42: 5‘AGTATACAAATGCACTQCAGAAAATACCATCG ( 3 2 m e r ) 
Figure 3- 8. Primer sequences for the amplification of P42, P19, MP42 and 
MP19 for phaseolin vacuolar-sorting signal constructs. 
Bold sequences represent the gene sequences of either P42, P19 (B), 
MP42 or MP 19 (A) as defined by the name of the primers. New 
restriction sites are labeled on top of the sequences. Italic sequences 
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A-Ndel AccI (VY) -A ^ ^ ^ 
Target gene | AF pGEM®-T 
，�l igat ion 
Ndel AccI (VY) 
V pGEM®-T/Target gene-AFVY ) 
J Ndel, AccI 
Ndel AccI (VY) 
Target gene AF Ndel AccI 
PhaSpro s p Phas ter ^ 
，�l i ga t ion 
40 
，�l igation 
////idlll Hinmi \ PhaSpro sp Target gene AFVY Phaster / 
v . pBK/Phas/sp/Target gene-AFVY 
Figure 3- 9. General scheme for construction of phaseolin vacuolar-sorting 
signal-containing constructs 
Target gene represents either P42, PI9，MP42 or MP 19. Other 
abbreviations are the same as Fig. 3- 7. 
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3.4.3 Confirmation of sequence fidelity of chimeric genes 
To check the sequence fidelity of the chimeric genes, cycle sequencing was 
performed using ABI PRISM® dRhodamine Terminator cycle sequencing kit 
(Applied Biosystems) and analyzed using ABI PRISM® 3100 Genetic Analyzer 
(Applied Biosystems) as described in the user manual. 
3.4.4 Cloning of chimeric genes into Agrobacterium binary vector 
Chimeric gene constructs (3.4.1 & 3.4.2) were excised by Hindlll (New 
England BioLabs) and ligated into the Agrobacterium-hmsLvy vector pBI121 carrying 
the neomycin phosphotransferase II (NPTII) selectable marker and P-glucurondiase 
(GUS) screenable marker genes (Figure 3- 10). The resulting plasmids were: 
r pBI/Phas/LRP12A/MP42 




Phaseolin vacuolar-sorting signal J pBI/Phas/sp/MP 19-AFVY 
constructs | pBI/Phas/sp/P42-AFVY 
L pBI/Phas/sp/P19/AFVY 
The resulting plasmids were then transformed into Agrobacterium tumefaciens 






RB^ NoSpro NPTI I Noster 十 35Spr� GUS Nostcr LB 
pBI121 ^ ^ ^ ^ ^ 
Figure 3- 10. Cloning of chimeric genes into Agrobacterium binary vector 
pBI121 
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3.5 Transgenic expression in Arabidopsis and tobacco 
3.5.1 Plant materials 
Arabidopsis thaliana ecotype Columbia-0 and Nicotiana tabacum L. cv 
Xanthin. nc were used in the study. 
3.5.2 Agrobacterium transformation 
By electroporation (Sambrook et al., 1989)，Agrobacterium tumefaciens 
GV3101/pMP90 (Koncz and Schell, 1986) was transformed with all the chimeric 
gene constructs (3.4.4) for Arabidopsis transformation, whereas Agrobacterium 
tumefaciens LBA4404/pAL4404 (Hoekema et al., 1983) was transformed with the 
targeting construct, pBI/Phas/sp/MP42-AFVY, for tobacco transformation. 
An aliquot (40|il) of Agrobacterium competent cells was thawed on ice. Then 
the competent cells were gently mixed on ice with l|il of plasmid DNA (-500 ng). 
The Gene Pulser apparatus (BioRad) was set as 25 |iF, 2.5 kV and 600 Ohm, and the 
cell-DNA mixture was transferred to a pre-chilled electroporation cuvette (Bio-Rad). 
Then an electric pulse was applied to the cuvette for 5 msec. After pulsing, 1 ml of 
LB (lOg/L NaCl, lOg/L bacto-tryptone and 5g/L yeast extract) was added to the 
cuvette. The cells were quickly resuspended and transferred to a 5ml polypropylene 
round-bottom tube (Falcon) with shaking at 28°C for 2 hours. Then 5|il, 50^1 and the 
4 4 
remaining cells were spread on LB plates supplemented with 50 mg/L rifampicin, 25 
mg/L gentamycin and 50 mg/L kanamycin. The plates were incubated at 28�C for 2 
days to select the transformed Agrobacterium colonies. 
3.5.3 Arabidopsis transformation and selection 
3.5.3.1 Arabidopsis transformation by vacuum infiltration 
Arabidopsis thaliana ecotype Columbia-0 was transformed as described by 
Bechtold et al. (1993). Seeds were first sowed onto soil and imbibed for 2 days at 
4°C. Then, they were allowed to germinate and grow for four to six weeks at 22°C 
with a light (daylight, 4000k lux) to dark cycle of 16 hours and 8 hours, respectively. 
When the primary inflorescence was 10-15 cm tall and the secondary inflorescence 
appearing at the rosette, the plants were then used in vacuum infiltration. Any 
siliques on the plants were cut off before infiltration. 
Prior to plant transformation, a single colony of A. tumefaciens 
GV3101/pMP90 containing the target gene (3.5.2) was cultured with shaking in 3 ml 
LB medium (lOg/L NaCl, lOg/L bacto-tryptone and 5g/L yeast extract) containing 
50mg/l rifampicin, kanamycin and 25mg/L gentamycin at 28°C. On the second day, 
1ml starter culture was sub-cultured in 500ml YEP (lOg/L bacto-peptone, lOg/L 
yeast extract and 5g/L NaCl) medium containing the same antibiotics until its OD500 
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> 2. The culture was then centrifuged at 7000rpm for 10 minutes and resuspended in 
1 L infiltration medium (2.2g/L MS salts, 50g.L sucrose, 0.5g/L MES, 0.044nM 
benzylaminopurine, and 0.02% silwet™ L-77，pH5.7). 
The resuspended culture was then poured into IL beaker and placed into a 
vacuum chamber. The plants were then inverted and soaked into the bacterial 
solution including the rosette. Vacuum was applied and the plants were allowed to 
stay under vacuum for 10 minutes when bubbles started to form. At the end of the 
treatment, vacuum was released and the plants were drained briefly. Finally, the 
plants were set upright using hollow plastic cylinders and were grown for seed 
collection. The seeds so harvested are the Ri seeds. 
3.5.3.3 Selection of successful transformants 
Transgenic seedlings (Ri generation) were selected on kanamycin medium. 
Briefly, about 2000 seeds were sterilized by Clorox (sodium hypochlorite, 5.25%) for 
3 minutes followed by 3 minutes washing in sterilized distilled water for 3 times. The 
sterilized seeds were then plated onto MS medium (4.3g/L MS salts (Gibco), 2% 
sucrose, 0.8% bacto-agar, pH5.7) containing 50mg/L kanamycin and incubated at 
4°C for 2 days. They were then grown in 22°C growth chamber with the same 
conditions as above. Successful transformants, which appeared as green plantlets in 
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selection medium, were selected out after 1 week and were transferred into MS 
square plate containing 50mg/L kanamycin for further growth. Selected 
transformants (Ri plants) of about 3-4 weeks old were then transferred into soil and 
grow for seed collection. The seeds so harvested were the R2 seeds. 
3.5.3.4 Selection for homozygous plants with single gene insertion 
For the selection of transgenic plants having single transgene insertion into one 
chromosome (single gene insertion), about 50 R2 seeds were sterilized and plated on 
selection medium containing kanamycin. By using Chi-square analysis, those give 3 
to 1 survival to death ratio were selected and grown as R2 plants. Seeds (r3) from R2 
plants were harvested and plated on selection medium for the selection of 
homozygosity of transgene insertion. Transgenic lines with all plants survived in the 
selection medium were selected for further expression analysis. 
3.5.4 Tobacco Transformation and Selection 
Leaf discs method was employed in transforming tobacco (Nicotiana tabacum 
L. cv Xanthin. nc) using Fisher and Guitinan's protocol (1995). Wild type tobacco 
seeds were sterilized as in 3.5.3.3. The sterilized seeds were then allowed to 
germinate in MS medium (4.3g/L MS salts (Gibco), 2% sucrose, 0.8% bacto-agar, 
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pH5.7) and grown in a 24°C growth chamber with a 16-hour photoperiod. After a 
month, leaves from the germinated Tobacco plants were used for 
Agrobacterium-mQdiatQd transformation. 
Prior to transformation, a single colony of A. tumefaciens LBA4404/pAL4404 
harboring the plasmid pBI/Phas/sp/MSPI42-AFVY (3.5.2) was cultured in 3ml LB 
medium (lOg/L NaCl, lOg/L bacto-tryptone and 5g/L yeast extract) containing 50 
mg/1 kanamycin and 25 mg/1 streptomycin at 28°C with shaking until ODeio > 1 • The 
bacterial culture was spun down, washed with MS liquid medium (MSL, Table 3- 1) 
for 3 times and resuspended in 3 ml MS liquid medium. Leaves from the wild type 
tobacco were cut into small pieces 0.7x0.7 cm^) with razor blade. The cut leaf 
explants were then submerged in diluted (1:10) Agrobacterium culture for 10 minutes. 
After blotting dry on sterile filter paper, the explants were placed on co-cultivation 
medium (CM, Table 3- 1). 
After 2 days co-cultivation at 24 °C, leaf explants were transferred onto 
shooting medium (SM, Table 3- 1) and incubated in growth chamber under the same 
conditions as above for callus induction and shoot formation. The leaf explants were 
transferred to fresh medium every 16-20 days. The regenerated shoots (1 to 3 cm in 
height) were cut off and inserted into rooting medium (RM, Table 3- 1) for rooting. 
Finally, the regenerated tobaccos were transferred to soil and grown in greenhouse. 
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Table 3- 1. Composition of tissue culture media 
MSL CM SM RM 
MS salts g/L (Gibco) 4.3 43 ^ 4.3 
Ix B5 vitamin + + + + 
Sucrose g/1 20 20 20 20 
BA mg/1 1 1 1 -
NAA mg/1 ^ (U (U -
Phytagel mg/1 - ^ ^ 0.9 
Kanamycin mg/1 - - 100 50 
Carbenicilin mg/1 - - 300 200 
MSL = MS liquid medium, CM = co-cultivation medium, 
SM = shooting medium, RM = rooting medium, 
BA = N6-benzyladenine, NAA = Naphthaleneacetic acid 
3.5.5 Genomic DNA isolation 
Genomic DNA was isolated from Arabidopsis or tobacco leaves using the 
CTAB protocol (Doyle et al., 1990). The DNA was suspended in 50 |al ddHiO. DNA 
concentrations were determined with a spectrophotometer by OD260 measurement. 
The qualities of DNA were checked by gel electrophoresis in a 1% agarose/ TAE 
(0.04M Tris-acetate and 1 \xM EDTA) gel. 
3.5.6 Southern blot analysis 
Genomic DNA (15 |ag) was digested overnight with BamHI (New England 
BioLab), separated on 1% agarose/ TAE gel and then transferred to nylon membrane 
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(positively charged, Roche) using VacuGeneXL Vacuum blotting System (Pharmacia 
Biotech). Hybridization and detection was performed according to the method 
described in the DIG Nucleic Acid Detection Kit (Roche). Single strand DIG-labeled 
DNA probes (modified or unmodified MSPI42&19) were prepared using DIG DNA 
labeling Kit (Roche) by PGR amplification using LANm42 or LAN42 (Figure 3- 5) 
and DIG-labeled dUTPs. 
3.5.7 Total silique RNA isolation 
Developing siliques of Arabidopsis were harvested and total RNA was 
extracted by the method as described by Altenbach et al (1989). The quality of the 
extracted RNA was checked by electrophoresis in 1% agarose/ formaldehyde gel. 
3.5.8 Northern blot analysis 
Total silique RNA (6 |ag) was first separated in 1% agarose/ formaldehyde gel 
and then transferred to nylon membrane (positively charged, Roche) using 
VacuGeneXL Vacuum blotting System (Pharmacia Biotech). Hybridization and 
detection was performed according to the method described in the DIG Nucleic Acid 
Detection Kit (Roche). Single strand DIG-labeled DNA probes (modified or 
unmodified MSPI42&19) were prepared as described in 3.5.6. 
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3.5.9 Protein extraction and SDS-PAGE 
Total seed protein was extracted from 0.04g mature Arabidopsis seeds by 
grinding the seeds into powder and mixing with 0.5ml protein extraction buffer 
[50mM Tris-HCl pH 8.0, O.IM NaCl and lOmM EDTA] plus IX Complete protease 
inhibitor cocktail (Roche). The homogenate was then centrifuged at 14,000 rpm for 
10 minutes at 4°C. The clear supernatant was transferred to a new eppendorf tube and 
saved as seed total protein extract. The protein concentration was determined by the 
Lowry method using the DC protein assay (Bio-Rad) with bovine serum albumin 
(BSA) as a standard. 
For SDS-PAGE (Laemmli, 1970)，seed total protein (50 |ig) was mixed with 
equal volume of 2x sample loading buffer (0.5M Tris-HCl, pH6.8, 10% SDS, 0.2M 
EDTA, trace amount bromophenol blue) with or without p-mercaptoethanol (4%). 
For samples with p-mercaptoethanol，they were further incubated at 99°C for 2 
minutes. All samples were separated by 12.5% SDS-PAGE. Electrode buffer 
containing 0.25M Tris, 1.92M glycine, 1% SDS (pH 8.3) was used in the 
electrophoresis. After electrophoresis, the gel was either stained in Coomassie blue 
solution (1 g/L Coomassie brilliant blue G-250, 1% methanol) or transferred to 
membrane for immuno-detection. Stained gel was destained in destaining solution 
(methanol: 100% glacial acetic acid : water, 20 : 6 : 55). 
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3.5.10 Western blot analysis 
After SDS-PAGE, protein samples were blotted onto PVDF membrane 
(Bio-Rad) using mini-Trans-blot system (BioRad) as described in the user manual. 
Electro-transfer was performed at constant voltage (100 V) for 90 minutes in transfer 
buffer (48mM Tris, 39mM Glycine, 20% methanol). The efficiency of the transfer 
was monitored by staining the transferred gel as in 3.5.9. 
The transferred membrane was first blocked in 5 % blotto (IX TBS, 5% 
Carnation non-fat dry milk) at room temperature for 1 hour and was then incubated 
with 3.3 |ig of monoclonal antibody MAb5.2 (from Prof. Ho, Dept.of Biochemistry, 
CUHK) in 10 ml of blotto at room temperature for 1 hour. The antibody was 
produced against purified parasite MSPl (Siddiqui et al,, 1986) and recognizes a 
disulfide-dependent conformational eptitope on MSPl 19 (Chang et al., 1989). After 
washing the membrane four times in TBST (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 
0.05 % Tween 20), the membrane was incubated in blotto containing alkaline 
phosphatase (AP)-conjugated goat anti-mouse immuno-globulin G (Bio-Rad) at a 
1:3000 dilution for 1 hour. The membrane was further washed by TBST, and the 
reactive protein bands were detected either by incubation with the enzyme colour 
substrate NBT-BCIP (Bio-Rad) or the AURORA chemiluminescent substrate 
solution (ICN). 
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For immuno-detection with anti-LRP serum (produced against purified LRP 
from winged bean in our lab; Wong, 2002), all procedures were the same except, the 
dilution used was 1:3000 and the secondary antibody was the AP-conjugated goat 
anti-rabbit immuno-globulin G (Bio-Rad). 
For immuno-detection with human serum from patients infected with P. vivax 
(from Prof. Wu, Dept. of Parasitology, Sun Yat-sen Univeristy, through Prof Fung, 
Dept. of Biology, CUHK)，the serum was first pre-absorbed with lOX wild-type 
Arabidopsis seed total protein (10 times the amount of the sample) overnight at 4 
and the primary incubation was carried out overnight at 4 °C in a 1 :10 dilution . 
Secondary antibody was the AP-conjugated goat anti-human polyvalent 
immuno-globulin (Sigma). 
3.5.11 Enterokinase digestion of recombinant LRP fusion protein 
Seed total proteins (180 ng) were digested with 0.25 U of recombinant 
Enterokinase (Novagen) in the provided buffer at room temperature. After 2, 4, 8 & 
24 hours, aliquots of the digestion mixture were drawn out and mixed with equal 
volume of 2x sample loading buffer. Samples were stored at —20 °C until further 
analysis by western blot (3.5.10). 
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3.5.12 Deglycosylation studies of recombinant MSPI42-AFVY 
Seed total proteins (50 |ig) were incubated with either 2000 U of 
endoglycosidase H (Endo H) or 2000 U of Peptide: N-glycosidase F (PNGase F) in 
the provided buffer (New England BioLabs) at room temperature. Aliquots were 
removed at 2 or 16 hours and mixed with equal amount of 2x sample loading buffer. 
Samples were stored at -20 °C until further analysis by western blot (3.5.10). 
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3.6 Confocal immunoflorescence studies of MSPI42-AFVY in tobacco 
3.6.1 Preparation of sections 
Mature seeds from transgenic tobacco transformed with the 
pBI/Phas/sp/MP42-AFVY construct or wild-type plant were fixed in FAA (50% 
ethanol, 10% formaldehyde, 5% ascetic acid) for 24 hrs at room temperature. 
Samples were then dehydrated with automated Enclosed Tissue Processor (ETP) as 
described in the user manual and embedded with paraffin wax. The embedded 
samples were sectioned (5 |im) on a rotary microtome and placed onto slides. 
Before labeling, paraffin on samples were removed by two changes of xylene 
for 2 min and samples were rehydrated by successive incubation in an ethanol series 
(100%, 95%, 85%, 70%, 50%, 30%，10%), followed by two changes of distilled 
water, all for 2 min each. 
3.6.2 Labeling of fluorescence probes 
The pre-treated sections were blocked in 5 % blotto (IX TBS, 5% Carnation 
non-fat dry milk) for 1.5 hrs. After two washes in PBST, rabbit polyclonal anti-a-TIP 
(from Prof. Jiang, Dept of Biology, CUHK) and mouse monoclonal antibodies 
MAb5.2 were incubated together with the sections at 4 °C overnight, with working 
dilution in buffer 2 (PBS, 1% BSA): 1:100，10 |ig/ml, respectively. After the primary 
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incubation, the sections were further washed three times in buffer 2 and incubated 
with rhodamine-conjugated anti-rabbit antibody and FITC-conjugated anti-mouse 
antibody (both diluted to 1:200，Jackson ImmunoResearch Laboratory Inc.) for one 
hour at room temperature. The labeled cells were washed twice with buffer 2 and, 
after adding the cover slip, sections were ready for viewing in a confocal microscope. 
3.6.3 Image collection 
Fluorescence images were collected using a Bio-Rad Radiance 2100 system 
with the LaserShape2000 software (Bio-Rad), with the following parameters: 60X 
objective oil lens (Nikon), IX zoom, optimal iris and 512 X 512 box size pixel. A 
FITC/rhodamine software program was used to collect images under conditions 
where no crossover between FITC and rhodamine emissions occured and the two 
images were collected sequentially from the same optical section. The FITC images 
were pseudocolored in green and the rhodamine images were pseudocolored in red. 
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3.7 Bacterial expression of MSPI42 and anti-serum production 
3.7.1 pET expression in E. coli 
The modified MSPI42 cDNA (MP42) was previously cloned into the multiple 
cloning site of the bacterial expression vector pET-30a (Novagen) by Zhang (Dept of 
Biology, CUHK). The recombinant plasmid (pET-MP42), shown in Figure 3-11， 
would express the His- & S-tagged MSPI42 protein (MW: 47.8 kDa). 
Ncol BamHI 
T7 Pro His-Tag S-Tag MP42 T7ter 
pET MP42 
Figure 3-11. The Structure of pET-MP42. 
The pET-MP42 retains the His«Tag®/thrombin/S'Tag™/enterokinase 
configuration of the pET-30a N-terminal to the transgene. T7pro： T7 
promoter and T7ter： T7 terminator. 
To induce expression of His-MSPl42 in the transformed E. coli BL21 (X DE3 
lysogen), a positive clone was inoculated in 5ml LB (50 |j,g/|il kanamycin) and 
incubated for 16hrs at 37°C as a starter culture. Two milliliters of the starter was 
sub-cultured into 100 ml of LB (50 \xg/\i\ kanamycin) for 3hrs at 37�C. Then, IPTG 
was added into to a final concentration of 1 mM, and the culture was further grown 
57 
for 3 more hours. The culture was centrifuged to recover the pellet of bacterial cells 
and the pellet was stored at -80°C until used. 
3.7.2 Purification of recombinant His-MSP^i 
Inclusion bodies, containing the recombinant protein, were first purified from 
the cell pellet. The cell pellet (from the 100 ml culture) was resuspended in 10 ml IX 
wash buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1 % Triton X-100) and 
lysozyme (Sigma) was added to a final concentration of 100 |xg/ml. After incubation 
at 30 °C for 15 min, the mixture was sonicated on ice using a microtip with the 
power level set at 4.5, at 40 % duty for 15-20 bursts. Then the insoluble fraction was 
washed twice in IX wash buffer and finally resuspended in 2 ml IX wash buffer. 
The purified inclusion bodies were subjected to SDS-PAGE for purification of 
the recombinant protein by gel elution. Equal amount (2 ml) of 2x sample loading 
buffer was added to the purified inclusion bodies and 500 i^l of the mixture was 
loaded for SDS-PAGE (3.5.9). By referring to the prestained MW marker, the gel 
corresponded to the recombinant His-MSPl42 was cut out and grounded in a 15-ml 
Falcon tube with a glass rod. Protein extraction buffer (50 mM Na2P04，pH 7.0，50 
mM NaCl) was added (w/v =1:1.5) and mixed for 3 hrs before recovering the 
supernatant. The purity and quantity of the purified His-MSPUi was checked by 
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SDS-PAGE, using BSA as standard. 
3.7.3 Immunization of rabbits 
Two rabbits were prepared by the Laboratory Animal Service Center (CUHK). 
A total of four immunizations were performed at 3-week interval by subcutaneous 
injections. Each injection consisted of 100 |ig of purified His-MSPl42 (3.7.2) and an 
equal volume of either complete Freund's adjuvant (for the V^  injection, Sigma) or 
incomplete Freund's adjuvant (for subsequent injections, Sigma). 
Blood samples were collected from the rabbits 5 days after the fourth injection. 
The blood samples were allowed to clot for 2 hr at room temperature, and were 
centrifuged to remove the blood cells at 4�C. The recovered serum was stored 
a t -20�C. 
To check the titer of the anti-serums, dot blotting was performed as described in 
(3.5.10)，whereas, to determine the specificity of the anti-serum, western blotting was 
performed (3.5.10). 
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Chapter 4: Results 
4.1 Transgenic analysis of lysine-rich protein fusion constructs 
4.1.1 Construction of the lysine-rich protein fusion constructs 
The four chimeric gene constructs pBI/Phas/LRP 12A/MP42, 
pBI/Phas/LRP12B/MP42, pBI/Phas/LRP12A/P42 and pBI/Phas/LRP12B/P42 (3.4.4) 
were constructed (Figure 4-1; LRPl: N-terminal section of LRP; LRP2: C-terminal 
section of LRP; A: no His-tag; B: with His-tag) and transformed into A. tumefaciens 
GV3101/pMP90 for Arabidopsis transformation. For simplicity, plants transformed 
with pBI/Phas/LRP 12A/MP42, pBI/Phas/LRP 12B/MP42, pBI/Phas/LRP12A/P42 or 
pBI/Phas/LRP12B/P42 would be named as LRP/MP42, LRP-His/MP42, LRP/P42 or 
LRP-His/P42, respectively. 
As shown in Figure 4-IB, correct restriction maps could be generated for the 
constructs and the identity and fidelity of target gene constructs were further 
confirmed by DNA sequencing (data not shown). 
6 0 
A pBI/Phas/LRP12A/MP42 
^ 4.0Kb • 
Hindlll Hindlll 
丄 PhaSpro L R P l E K M P 4 2 E K L R P l Phastcr 
pBI/Phas/LRP12B/MP42 
A 4.0Kb • 
Hindlll Hindlll 
~ H PhaSpro I LRPl I EK | MP42 | EK | LRP2 | His | Phaster I " -
pBI/Phas/LRP12A/P42 
< 1.4Kb — 2.6Kb • 
Hindlll HmdIII Hindlll 
PhaSpro LRPl EK P42 EK LRP2 Phaster 
pBI/Phas/LRP12B/P42 
^ ~ 1.4Kb X 2.6Kb • 
Hindlll Hinjdlll Hindlll 
丄「PhaSpro I LRPl I EK | P42 | EK | LRP2 His PhasteTh^ 





1.65 Figure 4-1. Cloning of the lysine-rich protein fusion constructs 
(A) Structure of the four LRP fusion constructs showing the position of 
the Hindlll sites and the fragment sizes (B) Restriction digestion of the 
recombinant plasmids by Hindlll. 
Key: 1: pBI/Phas/LRP 12A/MP42; 2: pBI/Phas/LRP 12B/MP42; 3: 
pBI/Phas/LRP12A/P42; 4: pBI/Phas/LRP12B/P42; M: 1 Kb plus DNA 
ladder (Invitrogen). 
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4.1.2 Selection of transgenic plants 
First generation transgenic plants (Ri) were selected out on kanamycin medium 
after Arabidopsis transformation for each of the chimeric gene constructs. The 
number of LRP/MP42，LRP-His/MP42, LRP/P42 and LRP-His/P42 transgenic plants 
selected out were 12，15, 10 and 8，respectively. To select heterozygous single gene 
insertion lines, the self-fertilized seeds (R2 seeds) of each of the Ri transgenic plants 
were further selected for 3 to 1 survival to death ratio on kananmycin medium, based 
on the Mendel's law for monohybrid cross (Table 4— 1). The Chi-square statistical 
test was used to determine the credibility of the survival ratio. The number of 
heterozygous LRP/MP42, LRP-His/MP42, LRP/P42 and LRP-His/P42 transgenic 
plants selected out were 7, 9，6 and 5，respectively. 
After selection of the single gene insertion lines, the self-fertilized seeds (r3 
seeds) of the positive R2 transgenic plants were selected again for homozygous for 
the transgene. All the seeds of homozygous lines survived on the selection medium 
(Table 4— 2). The number of homozygous LRP/MP42，LRP-His/MP42, LRP/P42 and 
LRP-His/P42 transgenic plants selected out were 6，5，4 and 3, respectively. 
The selected homozygous plants & their seeds were used in subsequent 
molecular analysis. 
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Table 4- 1: Selection of single gene insertion transgenic R2 Arabidopsis lines by 
Chi-square analysis. 
R2 plantlets, having 3 to 1 survival to death ratio, were the offsprings of a 
hemizygous transgenic Ri Arabidopsis. The validity of data was analyzed 
using Chi-square test at P value of 0.05 (chi-square = 3.84). "+" means P 
value > 0.05 (chi-square < 3.84) which indicates that the difference between 
the observed and predicted value was insignificant and thus being selected. 
Only positive lines were shown here. 
No. Survived No. Died Transgenic Ri plants Chi-square test (R2 plants) (R2 plants) 
LRP/MP42 lines  
1.1 64 25 + 
1.2 113 29 + 
2.1 110 30 + 
4.2 108 30 + 
5.1 94 37 + 
7.2 88 22 + 
^ 9丄 ^ + 
LRP-His/MP42 lines  
1.1 69 29 + 
1.2 55 23 + 
1.5 68 21 + 
2.2 55 24 + 
2.4 59 24 + 
3.3 85 25 + 
7.1 74 22 + 
9.2 69 28 + 
10.1 68 25 + 
LRP/P42 lines  
2.1 74 26 + 
2.2 68 25 + 
2.3 85 25 + 
4.1 74 28 + 
4.2 75 25 + 
5.3 69 22 + 
{Cont.) 
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LRP-His/P42 lines — 
3.4 71 29 + 
3.7 65 23 + 
3.8 72 24 + 
4.1 80 18 + 
^ 108 30 + 
(Table 4- l,Cont.) 
Table 4- 2: Selection of homozygous transgenic R3 Arabidopsis lines 
R3 transgenic lines with homozygous gene insertion all survived in the 
selection. 
















4.1.3 Southern analysis 
To confirm the transgene integration of the transformed line, Southern blotting 
was carried out. The genomic DNA of the homozygous lines was extracted and 
digested with BamHI. As the enzyme cuts only one time on the T-DNA backbone 
and do not cut the transgene, the copy number of the transgene integration could be 
estimated on the blot. 
The Southern blots of the LRP/MP42, LRP-His/MP42, LRP/P42 and 
LRP-His/P42 transgenic plants are shown in Figures 4— 2, 3 & 4, respectively. As 
can be seen on the blots, each of the homozygous transgenic lines was independent 
transformant and carried low to high numbers of transgene, from 1 (e.g. LRP/MP42 
line 4.2.6, Fig. 4- 2) to more than 6 copies (e.g. LRP/MP42 line 2.1.8, Fig. 4- 2). For 
all of the lines, about half of them carried low copy numbers (1 to 2) of the 
transgene. 
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LRP/MP42 transgenic plants 
WT M 1.2.8 2.1.8 4.2.6 7.2.1 10.1.9 m 
B ^ ^ m n 
wm • • 
mm • B 
4.9 一 ^ M f t 
H P - S ? 
3.6 一 mm 耀 m-： 
Copy no.: 4 >6 1 2 >6 
Figure 4- 2. Southern analysis of LRP/MP42 transgenic Arabidopsis 
(A) Genomic DNA (10|ig) was digested with BamHI and separated by 
gel electrophoresis. (B) The resolved DNA was blotted onto a nylon 
membrane for hybridization and detection. The estimated copy 
number(s) of the transgene in each line was also shown. Key: WT: wild 
type Col-0; M: DNA Molecular Weight Marker VII，DIG-labeled 
(Roche). 
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LRP-His/MP42 transgenic plants 
WT 1.5.4 1.6.1 3.3.4 7.1.3 
丨 : " 
：：_ I 
I I 通 
Copy no.: > 5 1 2 2 
Figure 4- 3. Southern analysis of LRP-His/MP42 transgenic Arabidopsis 
(A) Genomic DNA (lOjig) was digested with BamHI and separated by 
gel electrophoresis. (B) The resolved DNA was blotted onto a nylon 
membrane for hybridization and detection. The estimated copy 




LRP/P42 | ,RP-HiWP42_ 
WT 2.1.1 2.2.1 4.1.3 4.2.2 3.4.2 3.7.4 3.8.1 
B 
. . . . . . I ^ B i i w ^^m • IZK f i l Copy no.: 1 2 >6 4 4 2 3 
Figure 4- 4. Southern analysis of LRP/P42 and LRP-His/P42 transgenic 
Arabidopsis 
(A) Genomic DNA (10|ig) was digested with BamHI and separated 
by gel electrophoresis. (B) The resolved DNA was blotted onto a 
nylon membrane for hybridization and detection. The estimated copy 
number(s) of the transgene in each line was also shown. Key: WT: 
wild type Col-0. 
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4.1.4 Northern analysis 
To study the expression of the transgene at transcriptional level, northern blot 
analysis of total silique RNA was carried out (Figure 4- 5). 
For the LRP/MP42 and LRP-His/MP42 transgenic plants containing the 
plant-optimized MSPl42 cDNA, transcription of the transgene was detected in 3 out 
of 5 and 2 out of 4 transgenic lines, respectively (Figure 4- 5A&B). For the LRP/P42 
and LRP-His/P42 transgenic plants harboring the unmodified MSPI42 coding 
sequence, however, no transcript was detected in all of the lines (Figure 4- 5C). 
These results strongly suggest that the plant-optimized MSPI42 cDNA (MP42) has 
successfully enhanced the transcriptability of the MSPl42 cDNA (P42) in 
Arabidopsis. 
Further, the transcription of the MP42 in transgenic plants appears to show a 
degree of dependent on the number of transgene integration. The non-transcribed 
lines, 2.1.8 and 10.1.9，of LRP/MP42 (Figure 4- 2) and 1.5.4 of LRP-His/MP42 
(Figure 4- 3) all have high copy number of transgene, >6 and >5, respectively. As 
often observed in gene silencing, the higher the copy number of transgene, the higher 
chance of the transgene that would be silenced. 
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LRP/MP42 transgenic plants 
WT M 1.2.8 2.1.8 4.2.6 7.2.1 10.1.9 A CHIEOSEi 
f f • • 
Copy no.: 4 >6 1 2 >6 
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Figure 4- 5. Northern analysis of LRP/MP42, LRP-His/MP42, LRP/P42 and 
LRP-His/P42 transgenic Arabidopsis 
(A) LRP/MP42 homozygous lines. (B) LRP-His/MP42 homozygous lines. 
(C) LRP/P42 and LRP-His/P42 homozygous lines. For (A), (B) & (C)’ total 
siliques RNA (6 |ig) was resolved in 1% RNA denaturating gel (upper 
panel) and then used for northern blot hybridization and detection with the 
MP42 or P42 coding sequence accordingly (lower panel). Key: WT: wild 
type Col-0; M: 0.24-9.5Kb RNA ladder (Invitrogen). 
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4.1.5 Western analysis 
From the western blot analysis (Figure 4- 6), the recombinant LRP-MSPI42 
fusion protein was detected in the LRP/MP42 transgenic lines. However, it could not 
be detected in other constructs including LRP-His/MP42, LRP/P42 and 
LRP-His/P42. 
The LRP-MSPI42 fusion protein has a calculated MW of 61.6 kDa. From the 
immunoblot of LRP/MP42 (Figure 4- 6A), a protein band with similar size was 
detected in three of the lines. These three lines had also been shown to produce 
mRNA of MP42 by northern blot analysis (Figure 4- 5A). This protein detection 
provides strong evidence that the LRP/MP42 transgenic plants could produce the 
recombinant LRP-MSPI42 protein. 
Interestingly, however, no expression was detected in the LRP-His/MP42 
transgenic lines (which is exactly LRP/MP42 but with a C-terminal His-tag). Even 
though there were transcripts detected in the two LRP-His/MP42 transgenic lines 
1.6.1 & 7.1.3 (Figure 4- 5B), no protein was detected in these lines (Figure 4- 6B). 
To determine whether this was just a rare event in this two lines, another western blot 
of many more F2 heterozygous lines were performed (Figure 4- 6C). However, no 
protein was detected. This suggests that the LRP-His/MP42 could not express the 
recombinant protein or the protein would be too unstable for accumulation. 
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For the unmodified constructs, LRP12A/P42 and LRP12B/P42, there was no 
recombinant fusion protein detected in these transgenic lines (Figure 4- 6D). This is, 
however, expected, as the expression of chimeric genes should have been terminated 
at the transcriptional level (Figure 4- 5C). 
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Figure 4- 6. Western analysis of LRP-MSPI42 expression in LRP/MP42, 
LRP-His/MP42, LRP/P42 and LRP-His/P42 transgenic 
Arabidopsis 
(A) LRP/MP42 homozygous lines. (B) LRP-His/MP42 
homozygous lines. (C) LRP-His/MP42 heterozygous lines. (D) 
LRP/P42 and LRP-His/P42 homozygous lines. 
Total seed soluble proteins (50 |ag) were resolved in 12.5% 
SDS-PAGE without p-mercaptoethanol and blotted onto PVDF 
(Bio-Rad) membrane. Blots were detected using either MAb5.2 
(A), anti-MSPl42 serum (B) & (D) or anti-LRP serum (C) as 
primary antibody and alkaline phosphatase conjugated 
anti-species IgG as secondary antibody. In (B), (C) & (D)，protein 
sample from LRP12A/MP42 (line 1.2.8) was included as a 
positive control. The arrow shows the position of the expected 
LRP-MSPI42 fusion protein. Key: WT: wild type Col-0 and M: 
Precision Plus Protein Dual Color Standards (Bio-Rad). 
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4.1.6 Western analysis with anti-LRP 
To further prove the protein detected by the MSPl42-specific MAb5.2 
monoclonal antibody is the LRP-MSPI42 fusion protein, total protein extracts from 
seeds of line 1.2.8 of LRP/MP42 were loaded side-by-side and detected in a western 
blot with either anti-LRP serum or Mab5.2. 
As shown in Figure 4- 7, the immunoblot using anti-LRP detected a protein 
with the same size as that using MAb5.2, which again corresponds to the MW of the 
recombinant protein. This provides further evidence that the protein detected was the 
recombinant LRP-MSPI42 fusion protein. 
LRP/MP42 LRP/MP42 
transgenic plants transgenic plants 
1.2.8 WT 1.2.8 
禱： 
100 k D a — 




Figure 4- 7. Western analysis of LRP-MSPI42 expression in LRP/MP42 
transgenic Arabidopsis using MAb5.2 and anti-LRP serum 
Total seed soluble protein (50 |_ig) was resolved in 12.5% 
SDS-PAGE without (3-mercaptoethanol and blotted onto PVDF 
(Bio-Rad) membrane. Blots were detected using either MAb5.2 or 
anti-LRP serum (C) as primary antibody as shown and alkaline 
phosphatase conjugated anti-species IgG as secondary antibody. 
Key: WT: wild type Col-0. 
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4.1.7 Enterokinase digestion of recombinant LRP fusion protein 
In the design of the LRP-MSPI42 fusion construct, two enterokinase (EK) sites 
were incorporated in the fusion protein, flanking the transgene i.e. MP42 (Figure 4-
lA), which allows the possible release of the transgene product with the digestion by 
EK. This would be an important feature if only the target protein is required as the 
final product, as in the case of vaccine production. 
As the recombinant LRP-MSPI42 was expressed, the possible release by the 
enterokinase was investigated (Figure 4- 8). Theoretically, three protein fragments, 
LRPl-EK (5.5 kDa), MSPI42-EK (43 kDa) and LRP2 (12.5 kDa), would result from 
the digestion of the 61-kDa LRP-MSPI42 fusion protein. Their formations after 
digestion were traced by western blot analysis of the total soluble protein using 
anti-LRP and MAb5.2 antibodies. 
For the blots detected with anti-LRP serum (Figure 4- 8A)，lanes 1-4 showed 
the no EK time control of the seed total protein extract from the LRP12A/MP42 line 
1.2.8. Two bands were detected in these lanes: the LRP-MSPI42 fusion protein and a 
small size ( � 1 1 kDa) protein, possibly resulting from natural degradation during 
incubation. As incubation time increased, their amounts decreased. For lanes 5-8, 
where EK was included in the incubation, an additional band (marked with “/’’）was 
observed in lanes 5-7. This protein has a good match with the size of the LRP2 (12.5 
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kDa) and, together with the lesser amounts of the LRP-MSPI42 observed when 
compared with the control (lanes 1-4) during the progression of digestion, provides 
evidences for the digestion of LRP-MSPI42 by EK. Another fragment, LRPl-EK, 
though, would be too small (5.5 kDa) to be traced in this blot. 
However, for the blots using Mab5.2, the MSPI42-EK (43 kDa) fragment could 
not be detected. One possible reason might be that the released MSPI42-EK may be 
very unstable and degraded by proteases in the extracts quickly. Another reason 
might be, when release as MSPI42-EK by EK, the conformation of this protein would 
be altered. Since Mab5.2 recognizes a conformation epiptope on the MSPI42, this 
would leave the released MSPI42-EK undetected. 
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Figure 4- 8. Enterokinase digestion of recombinant LRP-MSPI42 fusion protein 
Total seed soluble protein from line 1.2.8 of LRP/MP42 (45 |ig) were 
digested by 0.048U of recombinant enterokinase (Novagen) or left 
alone for 2, 4, 8 & 24 hrs. Western blots (without p-mercaptoethanol in 
SDS-PAGE) of the samples were performed as in Figure 4- 7. Blots 
were detected using either anti-LRP serum (A) or MAb5.2 (B) as 
primary antibody. Key: EK: enterokinase; M: Precision Plus Protein 
Dual Color Standards (Bio-Rad); “ — ” shows the position of the 
LRP-MSPI42 and its fragment; “/，’ indicates the present of the LRP2 
fragment. 
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4.2 Transgenic analysis of phaseolin vacuolar-sorting signal 
constructs 
4.2.1 Construction of the phaseolin vacuolar-sorting signal constructs 
The four chimeric gene constructs pBI/Phas/sp/MP42-AFVY, 
pBI/Phas/sp/MP 19-AFVY, pBI/Phas/sp/P42-AFVY and pBI/Phas/sp/P19-AFVY 
(3.4.4) were constructed (Fig. 4- 9) and were transformed into A. tumefaciens 
GV3101/pMP90 for Arabidopsis transformation. For simplicity, plants transformed 
with pBI/Phas/sp/MP42-AFVY, pBI/Phas/sp/MP 19-AFVY, pBI/Phas/sp/P42-AFVY 
or pBI/Phas/sp/Pl 9-AFVY would be named as MP42-AFVY, MP 19-AFVY, 
P42-AFVY or PI 9-AFVY, respectively. 
As shown in Figure 4- 9B, these constructs showed expected restriction maps. 
In addition, DNA sequencing was performed to further confirm the fidelity of the 
constructs (data not shown). 
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Figure 4- 9. Cloning of the phaseolin vacuolar-sorting signal constructs 
(A) Structure of the four targeting constructs showing the position of 
the Hindlll sites and the fragment sizes (B) Restriction digestion of the 
recombinant plasmids by Hindlll. Key: 1: pBI/Phas/sp/MP42-AFVY; 
2: pBI/Phas/sp/MP 19-AFVY; 3: pBI/Phas/sp/P42-AFVY; 4: 
pBI/Phas/sp/Pl9-AFVY and M: 1 Kb plus DNA ladder (Invitrogen). 
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4.2.2 Selection of transgenic plants 
First generation transgenic plants (Ri) were selected out on kanamycin medium 
after Arabidopsis transformation for each of the chimeric gene constructs. The 
number of MP42-AFVY, MP 19-AFVY, P42-AFVY and PI9-AFVY transgenic 
plants selected out were 11，16，15 and 6，respectively. Heterozygous single gene 
insertion lines were selected as in 4.1.2 and the results of the selection of P42-AFVY 
and MP19-AFVY were shown in Table 4- 3 (for each constructs, 6 plants were 
selected our). For M42-AFVY transgenic plants, the majority of the seeds in the 3 to 
1 survival to death selection failed to germinate on repeated trials of different 
transgenic lines. Thus, heterozygous single gene selection and subsequent 
homozygous selection of MP42-AFVY could not be carried out. Though, the 
transgenic plants were able to grow to R3 generation with those survived on the 
selection medium. One possible reason might be that the expression of 
MSPl42-AFVY took place in those seeds to a high level that inhibited their 
germination. To test, the seeds could be grown on non-selection medium to see if all 
seeds could germinate normally. If a significant portion of those seeds fails to 
germinate, then the reason for not germinating might be due to other factors, rather 
than the lack of resistance gene. For P19-AFVY, the selection for single gene 
insertion is still in progress. 
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Four homozygous P42-AFVY lines were selected out (Table 4- 4)，while the 
selection of homozygous MP19-AFVY is still in progress. 
The selected R3 generation (homozygosity not confirmed) of MP42-AFVY and 
MP19-AFVY, homozygous R3 plants ofP42-AFVY and R2 generation ofP19-AFVY 
were used in subsequent molecular analysis. 
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Table 4- 3: Selection of single gene insertion transgenic R2 Arabidopsis lines by 
Chi-square analysis. 
R2 plantlets, having 3 to 1 survival to death ratio, were the offsprings of a 
hemizygous transgenic Ri Arabidopsis. The validity of data was analyzed 
using Chi-square test at P value of 0.05 (chi-square = 3.84). "+" means P 
value > 0.05 (chi-square < 3.84) which indicates that the difference between 
the observed and predicted value was insignificant and thus being selected. 
Only positive lines were shown here. 
No. Survived No. Died Transgenic Ri plants Chi-square test (R2 plants) (R2 plants) 
P42-AFVY lines  
4.1 79 21 + 
5.1 71 29 + 
5.3 73 27 + 
5.4 68 32 + 
7.1 64 20 + 
^ ^ ^ + 
MP19-AFVY lines  
1.2 52 20 + 
1.3 51 18 + 
4.1 52 21 + 
8.1 46 25 + 
8.2 54 24 + 
8.3 48 20 + 
Table 4- 4: Selection of homozygous transgenic R3 Arabidopsis lines 
R3 transgenic lines with homozygous gene insertion would all survive in the 
selection. 







4.2.3 Southern analysis 
To confirm the transgene integration in the transformed lines, Southern blotting 
was carried out as in 4.1.3. The genomic DNA of the transgenic lines was extracted 
and digested with BamHI. As the enzyme cuts only one time on the T-DNA 
backbone and do not cut the transgene, the copy number of the transgene integration 
could be estimated on the blot. 
The Southern blots of the MP42-AFVY, MP 19-AFVY, P42-AFVY and 
P19-AFVY are shown in Figures 4 - 10-12, respectively. Results showed that each of 
the homozygous transgenic lines was independent transformant and carried varying 
numbers of transgene, from 1 (e.g. MP42-AFVY line 6.4.1，Fig. 4- 10) to more than 
5 copies (e.g. PI 9-AFVY line 6.5’ Fig. 4- 12). For all of the lines, about 60% of them 
carried low copy numbers (1 to 2) of the transgene. 
85 
MP42-AFVY transgenic plants 
1.1.1 5.1.1 6.1.2 6.3.4 6.4.1 WT LiM 1 y 
B 
9 
Copy no.: 2 2 1 2 1 
Figure 4- 10. Southern analysis of MP42-AFVY transgenic Arabidopsis 
(A) Genomic DNA (lO^ig) of R3 generation of MP42-AFVY 
transgenic Arabidopsis was digested with BamHI and separated by gel 
electrophoresis. (B) The resolved DNA was blotted onto a nylon 
membrane for hybridization and detection. The estimated copy 
number(s) of the transgene in each line was also shown. Key: WT: 
wild type Col-0. 
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Figure 4- 11. Southern analysis of MP 19-AFVY transgenic Arabidopsis 
(A) Genomic DNA (lO^ig) of R3 generation of MP19-AFVY 
transgenic Arabidopsis was digested with BamHI and separated by gel 
electrophoresis. (B) & (C). The resolved DNA was blotted onto a 
nylon membrane for hybridization and detection. The estimated copy 
number(s) of the transgene in each line was also shown. Key: WT: 
wild type Col-0. 
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Figure 4- 12. Southern analysis of P42-AFVY and PI 9-AFVY transgenic 
Arabidopsis 
(A) Genomic DNA (10|ig) of homozygous generation of 
P42-AFVY and R2 generation of PI 9-AFVY transgenic 
Arabidopsis were digested with BamHI and separated by gel 
electrophoresis. (B) The resolved DNA was blotted onto a nylon 
membrane for hybridization and detection. The estimated copy 
number(s) of the transgene in each line was also shown. 
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4.2.4 Northern analysis 
To study the expression of the transgene at the transcriptional level, northern 
blot analysis of total silique RNA was carried out (Figure 4- 13). 
For the MP42-AFVY and MP 19-AFVY transgenic plants, transcription of the 
transgene was detected in all of these transgenic lines (Figure 4- 5A&B). For the 
P42-AFVY and P19-AFVY transgenic plants, however, no transcript was detected in 
all of the lines (Figure 4- 5C& D). These results, again, demonstrated that the 
plant-optimized MSPl 42 cDNA could enhance the transcription of the MSPl 42 cDNA 
and the stability of its transcript in Arabidopsis. 
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Figure 4- 13. Northern analysis of MP42-AFVY, MP19-AFVY, P42-AFVY and 
PI9-AFVY transgenic Arabidopsis 
(A) MP42-AFVY R3 lines. (B) MP19-AFVY R3 lines. (C) P42-AFVY 
homozygous lines. (D) P19-AFVY R2 lines. 
For (A), (B), (C) & (D)，total siliques RNA (6 \xg) was resolved in 1% 
RNA denaturating gel (upper panel) and then used for northern blot 
hybridization and detection with the MP42, MP 19，P42 or P19 coding 
sequence as a probe accordingly (lower panel). Key: WT: wild type 
Col-0 and M: 0.24-9.5Kb RNA ladder (Invitrogen). 
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4.2.5 Western analysis 
Western analysis was carried out to detect the expression of the MSPl proteins 
in transgenic Arabidopsis (Figure 4- 14). Results showed that recombinant 
MSP 142-AFVY and MSPl 19-AFVY were detected in the MP42-AFVY and 
MP 19-AFVY transgenic lines, respectively. However, no recombinant protein could 
be detected in the P42-AFVY and PI 9-AFVY transgenic lines. 
Based on previous studies, the size of MSPl42 and MSPl 19 in western blotting in 
non-reducing conditions would be 42 kDa and 19 kDa, respectively. Since the 
C-terminal AFVY contributes only four amino acids more, their expected sizes 
would be similar. 
From the immunoblot of MP42-AFVY (Figure 4- 14A), no signal was detected 
in the wild-type control (lane 1). But in the transgenic samples from different 
transgenic lines (lanes 2-6), two major bands (marked by two arrows) of sizes around 
40 kDa were detected, together with two slightly smaller bands (marked by two solid 
circles, sizes under 37 kDa) and two smaller proteins (marked by a vertical bar, sizes 
under 25 kDa). The two major bands, having sizes very close to the expected size, 
would likely be the mspi42 - A F V Y . The appearance of doublet proteins might be due 
to the glycosylation of the mspi42 - A F V Y , which would be further discussed in 
section 4.2.6. For the slightly smaller sizes proteins under 37 kDa (marked by 
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circles), they were suspected to be the degraded products of the two forms of the 
MSPI42AFVY, since there were exactly two of them and the signals of these smaller 
two bands increased when the incubation time of the protein extracts was extended 
(4.2.6). For the two smaller proteins under 25 kDa (marked by a vertical bar), they 
might again be the fragmentation products of the two forms of mspi42 - A F V Y . As in 
the case of the expression of phaseolin in heterologous plants, post-translational 
fragmentation of phaseolin is a characteristics that is often observed (Bagga et al” 
1992). This fragmentation has shown to be the result of transport to the heterologous 
vacuoles (Pedrazzini et al., 1997). Since the MSP 142 utilized the phaseolin 
vacuolar-sorting signal, fragmentation might have also occured in this case. 
In the western blots of MP19-AFVY (Figure 4- MB), again, no signal was 
detected in the wild-type control (lane 7). For the transgenic samples (lanes 1-6)， 
recombinant proteins were detected in all the lines, though the expression level 
varied among them. In addition, the transcriptional levels (Figure 4- 13B) of the 
m s p i 1 9 - A F V Y transgenic lines show no obvious correlation with their protein 
expression level. While the transcription in line 8.1.1 was very much higher than line 
1.2.1 (Figure 4- 13B), its protein level was actually lower than that of line 1.2.1 
(Figure 4- 14B). 
The expression pattern of the MP19-AFVY was rather complex. While the 
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protein at around 22.5 kDa would likely be the m s p i 1 9 - A F V Y (marked by an arrow), 
the identities of the proteins around 37 kDa and 60 kDa were obscure. They might be 
the dimer or trimer of the MSPI19-AFVY. However, upon western blot in reducing 
conditions, these proteins still remained. Thus, it is possible that the oligomerization 
of the MSP 119’ which has 12 cysteine residues, is quite strong structurally. 
For the unmodified constructs, P42-AFVY and P19-AFVY, no expression was 
detected in all these transgenic lines (Figure 4- 14C). This is expected, however, as 
the expression of the unmodified genes should have been terminated at the 
transcriptional level (Figure 4- 13C&D). 
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Figure 4- 14. Western analysis of MP42-AFVY, MP19-AFVY, P42-AFVY and 
PI9-AFVY transgenic Arabidopsis 
(A) MP42-AFVY R3 lines. (B) MP19-AFVY R3 lines. (C) P42-AFVY 
homozygous lines and P19-AFVY R2 lines. 
Total seed soluble proteins (50 jig) were resolved in 12.5% 
SDS-PAGE without P-mercaptoethanol and blotted onto PVDF 
(Bio-Rad) membrane. Blots were detected using either MAb5.2 (A) & 
(B) or anti-MSPl42 serum (C) as primary antibody and alkaline 
phosphatase conjugated anti-species IgG as secondary antibody. In (B) 
& (C)，protein sample from a line of MP42-AFVY or LRP12A/MP42 
was included as a positive control. Arrows show the position of the 
expected MSPI42-AFVY or MSPl 19-AFVY. Solid circles mark the 
possible degradation products of the MSPl42-AFVY. Vertical bar 
shows the fragmentation products of MSPl42-AFVY. Key: WT: wild 
type Col-0 and M: Precision Plus Protein Dual Color Standards 
(Bio-Rad). 
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4.2.6 Deglycosylation studies of recombinant MSPI42-AFVY 
As from the immunoblots of MP42-AFVY, two major proteins having the 
expected sizes were detected (marked with arrows, Figure 4- 14A). To determine 
whether the present of the two forms of mspi42 - A F V Y was resulted from 
glycosylation，deglycosylation of the total protein extracts by endoglycosidases was 
carried out, followed by western blotting. 
From the amino acid sequences of the mspi42 - A F V Y (Figure 4- 15 A), based on 
the present of Asn-Xaa-Ser/Thr stretch, two putative N-glycosylation sites, NIS at 
position 218 and NPT at 327, were located. But since, the putative NPT site has a 
proline just after the asparagine, it is highly unlikely that the asparagine is 
glycosylated, presumably due to conformational constraints. Thus, there would be at 
least one glycosylation site at 218 available for the glycosylation of mspi42 - A F V Y . 
Two endoglycosidases were used in this study: the Peptide: N-Glycosidase F 
(PNGaseF) and the Endoglycosidase H (Endo H). PNGaseF removes from 
glycoproteins the N-linked glycans of the high mannose, hybrid and complex type. 
PNGaseF sensitive protein indicates that the protein is a glycoprotein. On the other 
hand, the use of Endo H provides other information. Endo H removes only the high 
mannose type N-linked glycans from glycoproteins but not of the complex type. 
Because the complex type is acquired through the processing by glycosidases and 
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glycosyltransferases located in the medial and trans-Golgi complex, Endo H sensitive 
protein indicates that a glycoprotein has not encountered Golgi-processing enzymes 
and has not traveled through the Golgi. 
Total seed protein extract from line 6.1.2 of MP42-AFVY was treated with the 
endoglycosidases or without the enzyme as the control, followed by western blotting 
with MAb5.2 detection (Figure 4- 15B). Lanes 1 and 2 were the no enzyme control. 
Similar to the western blot in Figure 4- 14A, there were two forms of the 
m s p i 4 2 - A F V Y (marked with arrows) and the presumed degradation products of the 
two forms (marked with solid circles). One difference could be noticed, however, is 
that the signal of the degradation products, from where the samples were incubated 
for 2 hrs or more, increased, compared with the two forms of MSPl42-AFVY at �4 2 
kDa (see Figure 4- 14A). This supports that the two smaller proteins just below 37 
kDa is likely the degradation products of the two forms of mspi42 - A F V Y . 
For the samples treated with PNGaseF (lanes 5 and 6)，the slower migrating 
forms of the m s p i 4 2 - A F V Y (gray arrow) and its degradation product (gray circle) 
were sensitive to the enzyme digestion, as indicated by their co-migration with their 
faster migrating form (marked by black arrow and black circle respectively). This 
suggests that the slower migrating MSPl42-AFVY and its degradation product were 
glycosylated, while the faster migrating ones were not. Therefore, in the transgenic 
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Arabidopsis, it appears that about half of the expressed m s p i 4 2 - A F V Y were 
glycosylated and the other half were not. 
For the samples treated with endo H (lanes 3 and 4), the glycosylated form of 
m s p i 4 2 - A F V Y (gray arrow) was also sensitive and only the non-glycosylated form 
was detected (black arrow). As could be observed from the blot, the general signals 
of the endo H treated lanes decreased, which is a common character exhibited by the 
enzyme. This sensitivity of m s p i 4 2 - A F V Y to endo H, however, is not expected. 
Because in the transgenic expression of phaseolin in tobacco, it was shown that the 
phaseolin was transported through the Golgi complex to the storage vacuole (Frigerio 
et al., 1998)，so the resulting phaseolin was endo H resistance. Therefore, in this 
study, the result indicates that the MSPl42-AFVY either did not pass through the 
Golgi complex to the storage vacuole, which would represent a new pathway for the 
AFVY targeting in Arabidiopsis, or the structure of MSPl42-AFVY makes the glycan 
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Figure 4- 15. Deglycosylation studies of MSPI42-AFVY in transgenic Arabidopsis 
(A) Amino acid sequence of the recombinant MSPl42-AFVY. Underlined 
are the two putative N-glycosylation sites in the sequence. (B) Western blot 
of samples treated with or without endoglycosidase. Total seed soluble 
protein of MP42-AFVY was incubated with endoglycosidase H (endo H; +), 
with Peptide: N-Glycosidase F (PNGaseF; +) or without enzyme (-). 
Protein samples were analysed in 12.5% SDS-PAGE without 
P-mercaptoethanol and blotted onto PVDF (Bio-Rad) membrane. Blots 
were detected using MAb5.2 as primary antibody. The position of 
glycosylated (gray arrow) or unglycosylated (black arrow) m s p i 4 2 - A F V Y 
and that of glycosylated (gray circle) or unglycosylated (black circle) of the 
degradation products of MSPl42-AFVY are indicated. 
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4.2.7 Human serum detection of MSPI42-AFVY 
To test whether the recombinant MSPI42-AFVY produced in plant maintains its 
natural antigenicity, western blotting using human serum from patients infected with 
Plasmodium vivax was carried out. 
Since the C-terminal part of MSPI42, i.e. MSPI19, contains two EGF-like 
domains and is highly conserved both within and between Plasmodium species 
(Cooper, 1993)，the P. vivax patients' serum could be used to evaluate the natural 
antigenicity of the recombinant protein. 
From the immunoblot using the human serum (Figure 4- 16)，wild type control 
showed no signal at the 42 kDa position (lane 1). But for that of MP42-AFVY, the 
two forms of the m s p i 4 2 - A F V Y were detected. Therefore, this result demonstrated 





gel Q ^ ^ ^ ^ ^ m m m m 
after blotting 
< ~ glycosylated 
37 kDa — � 一 non-glycosylated 
1 2 
Figure 4- 16. Human serum detection of the MSPI42 in MP42-AFVY transgenic 
Arabidopsis 
Total seed soluble protein (50 |ig) was resolved in 12.5% 
SDS-PAGE without p-mercaptoethanol and blotted onto PVDF 
(Bio-Rad) membrane. Blots were detected using human serum from 
patients infected with P. vivax as primary antibody and alkaline 
phosphatase conjugated anti-human Immunoglobulins as secondary 
antibody. The positions of the two forms of the MSP 142-AFVY 
(arrows) are indicated. Key: WT: wild type Col-0. 
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4.3 Confocal immunofluorescence studies of MSPl42-AFVY in 
tobacco 
To investigate whether the phaseolin tetrapeptide AFVY could target MSPl42 to 
the protein storage vacuole (PSV), confocal immunofluoresence studies were carried 
out. As the seeds of Arabidopsis are too small to be used in confocal study, 
transgenic tobacco, transformed with pBI/Phas/sp/MP42-AFVY, was generated and 
its seeds were used in the present study. 
Single labeling of MP42-AFVY tobacco seeds with MSPlig-specfic MAb5.2 
detected signals in the cells of the embryo that were clearly distinguishable from the 
wild type (Figure 4- 17A). The signals appear to be confined to a vacuole-like 
structure. In addition, the results also agree with the findings that the phaseolin 
promoter in transgenic tobacco is embryo-specific (Bustos et al, 1989). 
To further confirm MSPI42-AFVY was located in the PSV, double labeling 
using both MAb5.2 and anti-a-TIP (tonoplast intrinsic protein) was performed. 
a-TIP is a membrane protein that is present on PSV tonoplast and could served as a 
marker for this sub-cellular compartment (Jauh, et al, 1999). From the double 
labeling results in Figure 4- 17B, the signals from MAb5.2 were located within the 
signals from anti-a-TIP. Therefore, this confocal studies show that MSPl42-AFVY is 
accumulated within the PSV and thus suggest that the phaseolin tetrpapetide could 
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target MSPI42 to thePSV 
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Figure 4- 17. Confocal immuno-fluorescence studies of seeds of MP42-AFVY 
transgenic tobacco. 
(A) Single labeling of seeds of either wild type (upper panel) or 
MP42-AFVY transformed tobacco (lower panel) with MAb5.2 antibody. 
Primary antibody was detected with FITC-conjugated (pseudocolored green) 
anti-mouse antibody. (B) Double labeling of MP42-AFVY transformed 
tobacco seeds with MAb5.2 and anti-a-TIP antibodies. Primary antibodies 
were detected with FITC-conjugated (pseudocolored green) anti-mouse 
antibody and deRhodamine-conjugated (pseudocolored red) anti-rabbit 
antibody. Key: DIC: differential interference contrast. 
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4.4 Bacterial expression of MSPI42 and anti-serum production 
4.4.1 Expression and purification of recombinant His-MSPl42 in E. coli 
The cDNA of the plant-optimized MSPl42 was cloned into the pET-30a 
expression vector and transformed into the expression host E. coli BL21 (X DE3 
lysogen). The induced protein, His-MSPl42, would have a calculated MW of 47.8 
kDa. 
From the SDS-PAGE of the induced and un-induced bacterial culture (Figure 4-
18A), a prominent band at around 50 kDa was observed in the induced sample (lane 
2) when compared with the un-induced sample (lane 1). This would be the expected 
recombinant His-MSPl42. To facilitate its purification, the insoluble inclusion bodies 
from the culture, which contain mostly the expressed protein, were isolated. The 
purified inclusion bodies were analyzed in SDS-PAGE (Figure 4- 18B, lane 1)， 
where the His-MSPl42 was found to be much concentrated. The final step of the 
purification of His-MSPUz was the gel-elution of the purified inclusion bodies. From 
the SDS-PAGE of the gel-eluted His-MSPl42 (Figure 4- 18B, lane 2)，the purity of it 
was confirmed and it was then used in rabbit immunization. 
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Figure 4-18. Expression and purification of His-MSPl42 in E�coll 
(A) The induced and un-induced culture samples of E. coli BL21 (X, 
DE3 lysogen) containing the pET-MP42-His were resolved in 12.5% 
SDS-PAGE and stained in Coomassie brilliant blue. (B) The purified 
inclusion bodies and the purified His-MSPUz were analyzed in 12.5% 
SDS-PAGE and stained in Coomassie brilliant blue. The positions of 
the His-MSPl42 (arrows) are indicated. Key: M: BenchMark Protein 
Ladder (Invitrogen). 
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4.4.2 Titer and specificity of the anti-serum 
Two rabbits were immunized with the purified His-MSPUi and the titer and 
specificity of their sera were analyzed 
Dot blotting of purified His-MSPUi using different dilutions of the sera were 
performed to determine their titers. In addition, seed protein extracts of MP42-AFVY 
and wild type were included to provide information on their specificity. From the dot 
blot (Figure 4- 19A), the anti-serum from rabbit #2 had a higher titer than rabbit #1 
as its serum gave a stronger signal at low dilutions. For the specificity of the sera, all 
but the 1:12000 dilution of rabbit #1 anti-serum showed a specificity comparable to 
the MAb5.2. Therefore, for future detection for MSP 142 in plants, 1:12000 dilution of 
rabbit #2 anti-serum should provide satisfactory results. 
To further determine the specificity of the serum in plant samples, western 
blotting using rabbit #2 anti-serum were carried out. As from the immunoblot (Figure 
4- 19B), the LRP-MSPI42 was successfully detected while no signal was detected in 
the wild type sample. Therefore, the specificity of the serum for use in detection of 
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Figure 4- 19. Titer and specificity of anti-His-MSPl42 sera 
(A) Dot blot of His-MSPl42 in different dilutions of anti-sera. (B) 
Total seed soluble proteins (50 |ag) were resolved in 12.5% 
SDS-PAGE without (3-mercaptoethanol and blotted onto PVDF 
(Bio-Rad) membrane. Blots were detected using anti-semm from 
rabbit #2 as primary antibody and alkaline phosphatase conjugated 
anti-rabbit IgG as secondary antibody. The positions of the 
LRP-MSPI42 (arrows) are indicated. Key: WT: wild type Col-0 and M: 
Precision Plus Protein Dual Color Standards (Bio-Rad). 
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Chapter 5 Discussion 
In this study, we have showed that the plant-optimized MSPl42 cDNA can allow 
transcription of the non-transcriptable native cDNA and the detection of intact 
transcript in transgenic plants. Furthermore, by fusing the transgene with the 
lysine-rich protein or the vacuolar-sorting signal from phaseolin, the accumulation of 
the recombinant MSPl42 was significantly enhanced. 
A few studies have reported that by removing the mRNA processing and 
destabilizing motifs and optimizing the codon usage, the expression levels of 
transgenes could be enhanced (Perlak et al, 1991; Mason et al., 1998). The increases 
in the expression of the modified genes were 100- {Bacillus thurigiensis crylA(b)) 
and 40- {E. coli LT-B) fold compared with the wild-type gene. Nevertheless, since 
both transcripts and proteins could still be detected even with the wild-type genes in 
those studies, our plant-optimized MSPl42 cDNA showed an even more dramatic 
result. At the transcriptional level, the plant-optimized cDNA enhanced its 
transcription drastically, from non-detectable in P42 lines to the full-length mRNA 
detected in MP42 lines. Those destabilizing and processing signals of MSPl42 cDNA, 
therefore, represent the major obstruction for successful transcription of MSPl42 in 
plant and the plant-optimized cDNA clearly demonstrated its enhancement on the 
transcription of MSPI42 to yield intact mRNA. 
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However, the sequence modification alone did not result in stable accumulation 
of recombinant MSPI42. From recent studies in our lab, the plant-optimized MSPl42, 
which was driven under either the 35S or phaseolin promoter, did not accumulate the 
recombinant protein to a detectable level in transgenic Arabidopsis, even though 
transcripts were detected in both cases (Chan, 2002; Wai, 2002). Since the codon 
usage of the cDNA was optimized, the absence of MSPl42 would unlikely be a result 
of low translational efficiency. A reasonable explanation could be that the normally 
secreted, cysteine-rich MSPl42 is not stable in the reducing environment of the 
cytosol, as discussed in 2.4. The fact that both the LRP fusion constructs, which fuse 
target protein to the stably expressed LRP, and the constructs with phaseolin 
vacuolar-sorting signal, which direct proteins to the sub-cellular compartment (PSV) 
for storage, allow recombinant MSPl42 to be detected, strongly suggests that the two 
strategies contribute crucially in stabilizing the recombinant MSPl42 and allowing its 
accumulation in plant cells. 
For the recombinant LRP fusion protein, LRP-MSPI42, it appears that it exists 
in a single molecular form, since only one band was detected in the western analysis 
with either anti-LRP or MAb5.2 (Figure 4- 7). The result agrees with the current 
speculation that LRP is a cytosolic protein and thus LRP-MSPI42 would not be 
glycosylated or fragmented in the vacuole like MSPI42-AFVY. Importantly, the 
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monoclonal antibody MAb5.2 used in the western blots is specific for a 
disulfide-dependent conformational eptitope on MSP 119, which is essential to its 
native antigenicity (Chang et al., 1992). Thus, the antigenicity of LRP-MSPI42, 
which could be recognized by MAb5.2, would likely be similar to the native MSP 142. 
In addition, in the enterokinase (EK) digestion of LRP-MSPI42 (Figure 4- 8), 
although digested LRP fragment was noted by anti-LRP, the release of MSPI42-EK 
could not be detected by MAb5.2. To test whether its absence was due to the 
degradation by proteases or its conformational change in the release, purification of 
LRP-MSPI42 fusion before digestion and the use of polyclonal ant-MSPl42 antibody 
in detection should answer the question. If it is due to proteases in the extracts, 
purification of LRP fusion protein should precede EK digestion to obtain intact 
MSPI42. If it is the result of conformational change in EK digestion, fusing MSPI42 
to C-terminal LRP in a form as: LRP::EK::MSPl42, rather than the present fusion: 
LRPl::EK::MSPl42::EK::LRP2，might give flexibility on the protein structure and 
might have a lower chance in inducing conformational change in EK digestion. 
On the other hand, recombinant proteins derived from the constructs with 
vacuolar-sorting signal have more complex expression patterns. MSPI42-AFVY 
exists in two form, glycosylated and non-glycosylated, together with the fragments or 
degradation products of the two forms (Figure 4- 14A). The presence of the 
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glycosylated form indicates that the proteins have entered the secretary pathway. The 
confocal immuno-fluorescence studies in tobacco seeds further demonstrated the 
recombinant protein was destined in the protein storage vacuole. The smaller 
fragments detected in the Western blot might be the result of proteases present in the 
vacuole, other possible processing in the secretary pathway, or degradation during 
extraction. Also, besides reacting with MAb5.2, MSPI42-AFVY could even be 
recognized by the human serum from malaria-infected patient. This gives strong 
evidence that the plant-derived MSP 142 maintains its natural antigencity and would 
have a high chance in inducing protective immunity in human. For the smaller 
MSPI19-AFVY, it again has a complex expression pattern (Figure 4- 14B), possibly 
due to the formation of dimers and trimers of MSP 1 9. MSP 119 also reacted with 
MAb5.2 and hence have a structure similar to the native form. 
A rough estimate on the expression level of MSPI42-AFVY based on dot 
blotting (Figure 4- 19A) was found to be 0.2% of the total soluble protein (TSP). As 
the previous report on expression of MSP 119 was only just 0.0035% TSP (Ghosh et 
al, 2002), the present expression level of MSPI42 shows a marked improvement in 
the expression of the malaria surface antigen in plant. This significant enhancement 
would be the result of the plant-optimized coding sequence and the vacuolar-sorting 
signal from phaseolin. In addition, when comparing to other vaccines expressed in 
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transgenic plants (Daniell et al., 2001)，the expression level of MSPl42 is comparable 
to the high expressions reported (Table 5.1). 
The effect of glycosylation of MSPl42 on its biological efficacy would be 
another factor to be considered. The baculovirus derived MSPl42, which offers 
protection against parasite challenge, are heterogeneous (with glycosylated and 
unglycosylated forms) and the sugars are of high mannose type (Chang et al, 1992; 
Chang et al., 1996). However, for the animal derived MSPI42, where the glycans are 
of complex type, offers no protection (Stowers et al, 2002). Protection was only 
observed when the putative glycosylation sites of MSPl42 have been removed. In our 
study, about half of the recombinant MSPl42-AFVY expressed in transgenic 
Arabidopsis was glycosylated and the sugars of the glycosylated proteins are of 
high-mannose type, as they are sensitive to endoglycanse H. Since the glycosylation 
pattern is similar to that of baculovirus derived MSPl42, the Ambidopsis-d&:Wed 
m s p i 4 2 - A F V Y would have a high chance to be immunologicaly efficacious. 
Interestingly, though, the glycans of the tobacco-derived MSPI42-AFVY are of 
complex type (resistant to endoglycanse H, data not shown). This probably reveals 
some minor difference in the protein trafficking machinery in different plants. To 
solve the problem completely, the putative N-linked glycosylation sites should be 
removed by amino acid substitutions as in the animal study or using a PSV targeting 
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pathway that bypass the Golgi apparatus (Jiang and Rogers, 1998). 
With the current expression level of plant-derived MSPl42, an obvious next step 
would be the purification of the protein for its protection against malaria in the Aotus 
monkey model. With the production of anti-MSPU?，the plant-derived MSPI42 could 
be affinity purified. Should the plant-derived MSPl42 offer protection, studies on its 
expression in other plant system, such as potato, soybean, its oral immunogenicity 
potential, aiming at its wide spread application, or other purification strategies should 
be investigated. 
As a whole, the present study depicts an excellent model for expressing foreign 
protein in transgenic plants. It is not until the use of plant-optimized MSPl42 cDNA 
and the strategies to stabilizing the protein that the recombinant MSPl42 could be 
successfully expressed. For a protein of interest, its transcriptability, codon usage, 
protein stability and cellular location should all be considered in the design of plant 
expression constructs. Addressing those criteria would be crucial in optimizing 
foreign protein production in plants. In the present study, the use of plant-optimized 
cDNA, LRP fusion construct and phaseolin targeting construct have shown to be an 
important tools in this context. Our strategies and findings on expressing a very 
unstable protozoan mRNA and protein, MSPI42, should be valuable in future 
development of plant expression systems or bioreactors. 
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Table 5- 1: Proteins with applications for human or animal vaccines and expressed by 
transgenic plants 
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Chapter 6 Conclusion 
We have shown here the enhancement of expression of the malaria surface 
antigen, MSPI42 and MSPl 19, in transgenic Arabidopsis. The plant-optimized 
MSPI42 and MSPl 19 cDNAs allow transcription of their non-transcriptable native 
cDNAs. Further, both the lysine-rich protein fusion and phaseolin AFVY 
vacuolar-sorting signal strategies enhance stable recombinant MSPl42 accumulation 
in plants. Importantly, the plant-derived MSPI42-AFVY showed native antigenicity 
and was targeted to protein storage vacuole. 
With the attained expression level (estimated to be 0.2% as total soluble protein), 
further work could be carried out to purify the recombinant MSPI42-AFVY and 
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